Medical and healthcare law Books

Book SynopsisOffers an innovative plan to eliminate inequalities in American health care and save the lives they endanger Over 84,000 black and brown lives are needlessly lost each year due to health disparities: the unfair, unjust, and avoidable differences between the quality and quantity of health care provided to Americans who are members of racial and ethnic minorities and care provided to whites. Health disparities have remained stubbornly entrenched in the American health care systemand in Just Medicine Dayna Bowen Matthew finds that they principally arise from unconscious racial and ethnic biases held by physicians, institutional providers, and their patients. Implicit bias is the single most important determinant of health and health care disparities. Because we have missed this fact, the money we spend on training providers to become culturally competent, expanding wellness education programs and community health centers, and even expanding access to health insurance will have only a moTrade Review"Just Medicine is a must-read for everyone! Weaving together from insights from research in history, sociology, psychology, law, and more, Matthew crushes the argument that racial disparities in health and health care are due to factors like biology and bad behavior. Time and time again, Matthew exposes the role of racial bias and discrimination in disparate outcomes. More so, she offers meaningful and achievable suggestions for resolving these problems. Lets hope those with the most power to create these changes are paying attention to this important scholarly contribution!" -- Angela Onwuachi-Willig,Charles M. and Marion J. Kierscht Professor of Law, University of Iowa College of Law"A powerful socio-legal reflection on the history of health disparities and how that terrible legacy now further impedes racial equality and results in death. . . . Masterfully written. The author provides a captivating narrative that is at once stark and grizzly (how many ways can people of color suffer at the hands of medicine) and yet so provocatively and artfully written that one cannot stop reading. Not since Harriet Washington's page-turning (and award-winning) book, Medical Apartheid, has there been another that makes medical discourse so captivating." -- Michele Goodwin,Chancellor’s Professor of Law, University of California, Irvine"A remarkably ambitious and provocative book on the ways that implicit bias exacerbates racial disparities in health. Matthew provides a critical analysis and call to action that should be taken seriously by all health care professionals, policymakers, and anyone interested in health equality." -- Osagie K. Obasogie,UC Hastings"The book is highly engaging and worthwhile reading for health care providers, hospital administrators, insurers, medical students and educators, and those involved in civil rights law." * Health Affairs *"Having presented a thorough picture of the problems facing minorities in the health care system, Matthew proposes a solution: reform of specific sections of the Civil Rights Act of 1964, which she claims would provide a legal and moral basis to hold liable those who unconsciously discriminate and would help to establish a new standard of care in medicine....[F]ood for thought here." * Kirkus Reviews *"Her ambitious book lays out a case for a legal remedy for racial health inequality." * Los Angeles Review of Books *"Just Medicine is necessary reading for all who envision a society in which health equity is a moral imperative. I would place Matthew's contributions on the scale of Michelle Alexander's transformational book, The New Jim Crow. Matthew not only documents the problem of color-blind racism but also provides solution-oriented road maps for a way forward." * Political Science Quarterly *"This book will spark much debate." * Choice Connect *Table of ContentsAcknowledgments xi Introduction: The New Normal 1 1. Bad Law Makes Bad Health 9 2. Implicit Bias and Health Disparities 33 3. Physicians' Unconscious Racism 55 4. From Impressions to Inequity: Connecting the Empirical Dots 75 5. Implicit Bias during the Clinical Encounter 106 6. Implicit Bias beyond the Clinical Encounter 128 7. From Inequity to Intervention: What Can Be Done about Implicit Bias 154 8. A Structural Solution 173 9. A New Normal: The Restoration of Title VI 195 Conclusion: Beyond Title VI 225 Notes 233 Index 265 About the Author 271

Read more less

Book SynopsisRonen Avraham, David Hyman and Charles Silver, leading authorities in their fields, discuss the effects of economic and legal constraints and regulation on healthcare. They examine the impact of access to healthcare on mortality and clinical outcomes and investigate healthcare financing, including payment to providers, expanding costs, health insurance and the provision of long-term care. The distribution of spending and the expansion of provision are also investigated. The regulatory aspect includes discussions on the regulation of healthcare practice, medical malpractice and liability, and public health and ethical issues.Table of ContentsContents: Volume I Introduction Ronen Avraham, David A. Hyman and Charles M. Silver PART I ACCESS TO HEALTHCARE: HEALTHCARE, MORTALITY AND OTHER CLINICAL OUTCOMES 1. Andrew P. Wilper, Steffie Woolhandler, Karen E. Lasser, Danny McCormick, David H. Bor and David U. Himmelstein (2009), ‘Health Insurance and Mortality in US Adults’, American Journal of Public Health, 99 (12), December, 2289–95 2. Richard Kronick (2009), ‘Health Insurance Coverage and Mortality Revisited’, HSR: Health Services Research, 44 (4), August, 1211–31 3. Katherine Baicker, Sarah L. Taubman, Heidi L. Allen, Mira Bernstein, Jonathan H. Gruber, Joseph P. Newhouse, Eric C. Schneider, Bill J. Wright, Alan M. Zaslavsky and Amy N. Finkelstein (2013), ‘The Oregon Experiment – Effects of Medicaid on Clinical Outcomes’, New England Journal of Medicine, 368 (18), May 2, 1713–22 PART II FINANCING HEALTH CARE A Payment Structure and Incentives 4. Ching-to Albert Ma and Thomas G. McGuire (1997), ‘Optimal Health Insurance and Provider Payment’, American Economic Review, 87 (4), September, 685–704 5. Sherry Glied and Joshua Graff Zivin (2002), ‘How Do Doctors Behave When Some (But Not All) of Their Patients are in Managed Care?’, Journal of Health Economics, 21 (2), March, 337–53 6. Thomas L. Greaney (2009), ‘Economic Regulation of Physicians: A Behavioral Economics Perspective’, Saint Louis University Law Journal, 53, 1189–209 7. Austin B. Frakt (2011), ‘How Much Do Hospitals Cost Shift? A Review of the Evidence’, Milbank Quarterly, 89 (1), March, 90–130 B Cost Drivers 8. Joseph P. Newhouse (1992), ‘Medical Care Costs: How Much Welfare Loss?’, Journal of Economic Perspectives, 6 (3), Summer, 3–21 9. Burton A. Weisbrod (1991), ‘The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment’, Journal of Economic Literature, XXIX (2), June, 523–52 10. Einer Elhauge (1997), ‘The Limited Regulatory Potential of Medical Technology Assessment’, Virginia Law Review, 82, 1525–617 C Health Insurance 11. Kenneth J. Arrow (1963), ‘Uncertainty and the Welfare Economics of Medical Care’, American Economic Review, LIII (5), December, 941–73 12. Mark V. Pauly (1968), ‘The Economics of Moral Hazard’, American Economic Review, 58 (3), Part I, June, 531–7 13. Kenneth J. Arrow (1968), ‘The Economics of Moral Hazard: Further Comment’, American Economic Review, 58 (3), Part 1, June, 537–9 14. Katherine Baicker and Amitabh Chandra (2008), ‘Myths and Misconceptions about U.S. Health Insurance’, Health Affairs, 27 (6), October, w533–w543, content.healthaffairs.org, accessed 13 August 2013 15. Sherry A. Glied (2005), ‘The Employer-Based Health Insurance System: Mistake or Cornerstone?’, in David Mechanic, Lynn B. Rogut, David C. Colby and James R. Knickman (eds), Policy Challenges in Modern Health Care, Chapter 3, Piscataway, NJ: Rutgers University Press, 37–52 D Moral Hazard and Adverse Selection 16. John A. Nyman (2004), ‘Is “Moral Hazard” Inefficient? The Policy Implications of a New Theory’, Health Affairs, 23 (5), September–October, 194–9 17. David M. Cutler and Sarah J. Reber (1998), ‘Paying for Health Insurance: The Trade-off between Competition and Adverse Selection’, Quarterly Journal of Economics, 113 (2), May, 433–66 E Long-Term Care 18. Mark V. Pauly (1990), ‘The Rational Nonpurchase of Long-Term-Care Insurance’, Journal of Political Economy, 98 (1), February, 153–68 19. Jeffrey R. Brown and Amy Finkelstein (2011), ‘Insuring Long-Term Care in the United States’, Journal of Economic Perspectives, 25 (4), Fall, 119–41 and ‘Appendix: Calculating Loads and Comprehensiveness’, http://www.aeaweb.org/articles.php?doi=10.1257/jep.25.4.119. Accessed 25.02.2014, 1-13 PART III DISTRIBTUTION OF SPENDING AND CROWD-OUT 20. Katherine Baicker, Amitabh Chandra and Jonathan S. Skinner (2005), ‘Geographic Variation in Health Care and the Problem of Measuring Racial Disparities’, Perspectives in Biology and Medicine, 48 (1), Supplement, Winter, S42–S53 21. Tomas J. Philipson, Seth A. Seabury, Lee M. Lockwood, Dana P. Goldman and Darius N. Lakdawalla (2010), ‘Geographic Variation in Health Care: The Role of Private Markets’ and ‘Comment and Discussion’, Brookings Papers on Economic Activity, Spring, 325–55, 56–61 22. David M. Cutler and Jonathan Gruber (1996), ‘Does Public Insurance Crowd out Private Insurance?’, Quarterly Journal of Economics, 111 (2), May, 391–430 PART IV COMPETITION AND FRAGMENTATION IN THE HEALTH CARE INDUSTRY 23. David Hyman (2010), ‘Health Care Fragmentation: We Get What We Pay For’, in Einer Elhauge (ed.), Fragmentation of U.S. Health Care: Causes and Solutions, Chapter 2, Oxford, UK: Oxford University Press, 23–36 24. Thomas (Tim) Greaney (2009), ‘Competition Policy and Organizational Fragmentation in Health Care’, University of Pittsburgh Law Review, 71 (2), 217–39 Index Volume II Contents: An introduction to both volumes by the editors appears in Volume I PART I REGULATION OF HEALTH CARE PRACTICE A Drugs and Devices 1. Anup Malani and Tomas Philipson (2012), ‘The Regulation of Medical Products’, in Patricia Danzon and Sean Nicholson (eds), Oxford Handbook of the Economics of the Biopharmaceutical Industry, Chapter 5, Oxford, UK: Oxford University Press, 100–42 2. Michelle M. Mello, Sara Abiola and James Colgrove (2012), ‘Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Huyman Papillomavirus Vaccination’, American Journal of Public Health, 102 (5), May, 893–8 B Licensure and Guidelines 3. Ronen Avraham (2011), ‘Clinical Practice Guidelines – The Warped Incentives in the U.S. Healthcare System?’, American Journal of Law and Medicine, 37 (1), Spring, 7–40 4. Shirley Svorny (1993), ‘Advances in Economic Theories of Medical Licensure’, Federation Bulletin: The Journal of Medical Licensure and Discipline, 80 (1), Spring, 27–32 C Provider Rankings 5. Peter K. Lindenauer, Denise Remus, Sheila Roman, Michael B. Rothberg, Evan M. Benjamin, Allen Ma and Dale W. Bratzler (2007), ‘Public Reporting and Pay for Performance in Hospital Quality Improvement’, New England Journal of Medicine, 356 (5), February, 486–96 6. David Dranove, Daniel Kessler, Mark McClellan and Mark Satterthwaite (2003), ‘Is More Information Better? The Effects of “Report Cards” on Health Care Providers’, Journal of Political Economy, 111 (3), June, 555–88 PART II MEDICAL MALPRACTICE AND LIABILITY 7. Richard A. Epstein (1976), ‘Medical Malpractice: The Case for Contract’, American Bar Foundation Research Journal, 1 (1), 87–149 8. Jennifer Arlen (2013), ‘Economic Analysis of Medical Malpractice Liability and Its Reform’, in Jennifer Arlen (ed.), Research Handbook on the Economics of Tort, Chapter 2, Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing Ltd, 33–69 9. Kenneth S. Abraham and Paul C. Weiler (1994), ‘Enterprise Medical Liability and the Evolution of the American Health Care System’, Harvard Law Review, 108 (2), December, 381–436 10. Kathryn Zeiler, Bernard S. Black, Charles Silver, David A. Hyman and William M. Sage (2008), ‘Physicians’ Insurance Limits and Malpractice Payments: Evidence from Texas Closed Claims, 1990-2003’, Journal of Legal Studies, 36 (S2), June, S9–S45 11. David M. Studdert, Michelle M. Mello, Atul A. Gawande, Tejal K. Gandhi, Allen Kachalia, Catherine Yoon, Ann Louise Puopolo and Trojen A. Brennan (2006), ‘Claims, Errors, and Compensation Payments in Medical Malpractice Litigation’, New England Journal of Medicine, 354 (19), May, 2024–33 12. Daniel Kessler and Mark McClellan (1996), ‘Do Doctors Practice Defensive Medicine?’, Quarterly Journal of Economics, 111 (2), May, 353–90 13. Daniel P. Kessler (2011), ‘Evaluating the Medical Malpractice System and Options for Reform’, Journal of Economic Perspectives, 25 (2), Spring, 93–110 14. Ronen Avraham, Leemore S. Dafny and Max M. Schanzenbach (2012), ‘The Impact of Tort Reform on Employer-Sponsored Health Insurance Premiums’, Journal of Law Economics and Organization, 28 (4), October, 657–86 15. Janet Currie and W. Bentley MacLeod (2008), ‘First Do No Harm? Tort Reform and Birth Outcomes’, Quarterly Journal of Economics, 123 (2), May, 795–830 PART III PUBLIC HEALTH A Infections and Antibiotic Resistance 16. Ramanan Laxminarayan and Anup Malani (2011), ‘Economics of Infectious Diseases’, in Sherry Glied and Peter C. Smith (eds), Oxford Handbook of Health Economics, Chapter 9, Oxford, UK: Oxford University Press, 189–205 17. William M. Sage and David A. Hyman (2010), ‘Combatting Antimicrobial Resistance: Regulatory Strategies and Institutional Capacity’, Tulane Law Review, 84 (4), March, 781–840 B Obesity 18. Ronen Avraham and K.A.D. Camara (2007), ‘The Tragedy of Human Commons’, Cardozo Law Review, 29 (2), November, 479–511 [33] 19. Tomas Philipson (2001), ‘The World-Wide Growth in Obesity: An Economic Research Agenda’, Health Economics, 10, 1–7 20. Tomas J. Philipson and Richard A. Posner (2008), 'Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy', Journal of Economic Literature, 46 (4), December, 974–82 PART IV ETHICAL ISSUES 21. Ezekiel J. Emanuel and Margaret P. Battin (1998), ‘What are the Potential Cost Savings from Legalizing Physician-Assisted Suicide?’, New England Journal of Medicine, 339 (3), July, 167–72 22. Judd B. Kessler and Alvin E. Roth (2012), ‘Organ Allocation Policy and the Decision to Donate’, American Economic Review, 102 (5), August, 2018–47 23. Jason Snyder (2010), ‘Gaming the Liver Transplant Market’, Journal of Law, Economics, and Organization, 26 (3), December, 546–68 Index

Read more less

Book SynopsisThis two-volume set gathers together some of the most significant contributions to the study of global health law. Global health law is a recent field of research in its own right, encompassing the relatively narrow core of international rules and institutions devoted to health protection and promotion, as well as the complex interactions between health and multiple areas of international law. By bringing such diverse perspectives into a single collection, together with an original introduction by the editor, this book will be an important resource for scholars and practitioners both in public health as well as in legal and policy fields such as trade and investment, human rights and the environment.Trade Review‘This is an indispensable collection of seminal contributions to global health law. Global health law has come a long way in a short time, but it remains in its infancy. The issues are huge, complex and vital – and they demand interdisciplinarity. As we search for global approaches to global health problems, these twin volumes of primarily legal perspectives will provide an extremely rich resource.’ -- Paul Hunt, University of Essex School of Law, UKTable of ContentsContents: Volume I Introduction Gian Luca Burci PART I GLOBAL HEALTH LAW IN GENERAL AND GLOBAL HEALTH GOVERNANCE 1. Gian Luca Burci (2009), ‘Public/Private Partnerships in the Public Health Sector’, International Organizations Law Review, 6 (2), 359–82 2. David P. Fidler (1999), ‘International Law and Global Public Health’, University of Kansas Law Review, 48 (1), November, 1–58 3. Lawrence O. Gostin (2008), ‘Global Health: Meeting Basic Survival Needs of the World’s Least Healthy People: Toward a Framework Convention on Global Health’, Georgetown Law Journal, 96 (2), January, 331–92 4. Lawrence O. Gostin and Allyn L. Taylor (2008), ‘Global Health Law: A Definition and Grand Challenges’, Public Health Ethics, 1 (1), April, 53–63 5. Jonathan Liberman (2012), ‘Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance’, Journal of Law, Medicine and Ethics, 40 (2), Summer, 326–47 6. Jennifer Prah Ruger (2008), ‘Normative Foundations of Global Health Law’, Georgetown Law Journal, 96 (2), January, 423–43 PART II WORLD HEALTH ORGANIZATION AND GLOBAL HEALTH LAW 7. David P. Fidler (1998), ‘The Future of the World Health Organization: What Role for International Law?’, Vanderbilt Journal of Transnational Law, 31 (5), November, 1079–126 8. Allyn Lise Taylor (1992), ‘Making the World Health Organization Work: A Legal Framework for Universal Access to the Conditions for Health’,American Journal of Law and Medicine, XVIII (4), 301–46 9. Allyn L. Taylor, Lenias Hwenda, Bjørn-Inge Larsen and Nils Daulaire (2011), ‘Stemming the Brain Drain — A WHO Global Code of Practice on International Recruitment of Health Personnel’, New England Journal of Medicine, 365 (25), December, 2348–51 10. Gaudenz Silberschmidt, Don Matheson and Ilona Kickbusch (2008), ‘Creating a Committee C of the World Health Assembly’, The Lancet, 371, May, 1483–6 PART III COMMUNICABLE DISEASES AND GLOBAL HEALTH SECURITY 11. Obijiofor Aginam (2005), ‘Bio-Terrorism, Human Security and Public Health: Can International Law Bring Them Together in an Age of Globalization?’, Medicine and Law, 24 (3), September, 455–62 12. David P. Fidler (2003), ‘Public Health and National Security in the Global Age: Infectious Diseases, Bioterrorism, and Realpolitik’, George Washington International Law Review, 35, 787–856 13. David P. Fidler (2005), ‘From International Sanitary Conventions to Global Health Security: The New International Health Regulations’, Chinese Journal of International Law, 4 (2), November, 325–92 14. K. Lee and D. Fidler (2007), ‘Avian and Pandemic Influenza: Progress and Problems with Global Health Governance’, Global Public Health, 2 (3), July, 215–34 15. Barbara von Tigerstrom (2005), ‘The Revised International Health Regulations and Restraint of National Health Measures’, Health Law Journal, 13, 35–76 16. Gian Luca Burci (2014), ‘Ebola, the Security Council and the Securitization of Public Health’, Questions of International Law: Zoom In, 10, December, 27–39 PART IV INTERNATIONAL TOBACCO CONTROL: THE WORLD HEALTH ORGANIZATION FRAMEWORK CONVENTION ON TOBACCO CONTROL 17. Alberto Alemanno and Enrico Bonadio (2011), ‘Do You Mind My Smoking? Plain Packaging of Cigarettes Under the TRIPS Agreement’, John Marshall Review of Intellectual Property Law: Special Issue, 10 (3), 450–75 18. Oscar A. Cabrera and Lawrence O. Gostin (2011), ‘Human Rights and the Framework Convention on Tobacco Control: Mutually Reinforcing Systems’, International Journal of Law in Context: Special Issue: Health and Human Rights, 7 (3), September, 285–303 19. Carolyn Dresler and Stephen Marks (2006), ‘The Emerging Human Right to Tobacco Control’, Human Rights Quarterly, 28 (3), August, 599–651 20. Jonathan Liberman (2014), ‘The Power of the WHO FCTC: Understanding its Legal Status and Weight’, in Andrew D. Mitchell and Tania Voon (eds), The Global Tobacco Epidemic and the Law, Chapter 4, Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing, 48–63 21. Sean D. Murphy (2003), ‘Liability and the WHO Framework Convention on Tobacco Control’, International Law FORUM du droit international, 5 (1), February, 62–71 22. Tania Voon (2013), ‘Flexibilities in WTO Law to Support Tobacco Control Regulation’, American Journal of Law and Medicine, 39 (2–3), 199–217 23. Tania Voon and Andrew Mitchell (2011), ‘Time to Quit? Assessing International Investment Claims against Plain Tobacco Packaging in Australia’, Journal of International Economic Law, 14 (3), September, 515–52 Volume II Introduction An introduction by the editor appears in Volume I PART I NON-COMMUNICABLE DISEASES 1. Roger S. Magnusson (2007), ‘Non-Communicable Diseases and Global Health Governance: Enhancing Global Processes to Improve Health Development’, Globalization and Health, 3 (2), May, 1–16 2. A. Mitchell and T. Voon (2011), ‘Implications of the World Trade Organization in Combating Non-Communicable Diseases’, Public Health, 125 (12), December, 832–9 3. Allyn L. Taylor and Ibadat S. Dhillon (2013), ‘An International Legal Strategy for Alcohol Control: Not a Framework Convention —At Least Not Yet’, Addiction, 108 (3), March, 450–55 4. Bryan Thomas and Lawrence O. Gostin (2013), ‘Tackling the Global NCD Crisis: Innovations in Law and Governance’, Journal of Law, Medicine and Ethics: Special Issue: Symposium: Global Health and the Law, 41 (1), Spring, 16–27 5. Tania Voon (2013), ‘WTO Law and Risk Factors for Non- Communicable Diseases: A Complex Relationship’, in Geert van Calster and Denise Prévost (eds), Research Handbook on Environment, Health and the WTO, Chapter 13, Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing, 390–408 6. Benn McGrady and Alexandra Jones (2013), ‘Tobacco Control and Beyond: The Broader Implications of United States—Clove Cigarettes for Non-Communicable Diseases’, American Journal of Law and Medicine, 39 (2–3), 265–89 PART II HEALTH AND INTERNATIONAL ECONOMIC LAW A International Trade Law 7. Jeffery Atik (2009), ‘Trade and Health’, in Daniel Bethlehem, Donald McRae, Rodney Neufeld and Isabelle van Damme (eds), The Oxford Handbook of International Trade Law, Chapter 21, Oxford, UK and New York, NY, USA: Oxford University Press, 597–618 8. Panagiotis Delimatsis (2013), ‘GATS and Public Health Care: Reflecting on an Uneasy Relationship’, in Geert van Calster and Denise Prévost (eds), Research Handbook on Environment, Health and the WTO, Chapter 12, Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing, 363–89 9. Allyn L. Taylor (2007), ‘Addressing the Global Tragedy of Needless Pain: Rethinking the United Nations Single Convention on Narcotic Drugs’, Journal of Law, Medicine and Ethics: Symposium, 35 (4), Winter, 556–70 B International Intellectual Property Rights Law 10. Frederick M. Abbott (2005), ‘The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health’, American Journal of International Law, 99 (2), April, 317–58 11. Philippe Cullet (2003), ‘Patents and Medicines: The Relationship between TRIPS and the Human Right to Health’, International Affairs, 79 (I), January, 139–60 C International Investment Law 12. Valentina S. Vadi (2012), ‘Global Health Governance at a Crossroads: Trademark Protection v. Tobacco Control in International Investment Law’, Stanford Journal of International Law, 48 (1), 93–130 13. Rahim Moloo and Justin Jacinto (2011), ‘Environmental and Health Regulation: Assessing Liability Under Investment Treaties’, Berkeley Journal of International Law, 29 (1), 1–65 D Pharmaceutical Research and Development 14. Steven J. Hoffman and John-Arne Røttingen (2012), ‘Assessing Implementation Mechanisms for an International Agreement on Research and Development for Health Products’, Bulletin of the World Health Organization, 90 (11), November, 854–61, 863 15. Dawn Joyce Miller (2001), ‘Research and Accountability: The Need for Uniform Regulation of International Pharmaceutical Drug Testing’, Pace International Law Review, 13 (1), Spring, 197–232 PART III HEALTH AND HUMAN RIGHTS: THE RIGHT TO HEALTH 16. L. Gable, L. Gostin and J.G. Hodge, Jr. (2009), ‘A Global Assessment of the Role of Law in the HIV/AIDS Pandemic’, Public Health: Special Issue, 123 (3), March, 260–64 17. Sofia Gruskin (2004), ‘Is There a Government in the Cockpit: A Passenger’s Perspective or Global Public Health: The Role of Human Rights’, Temple Law Review, 77 (2), Summer, 313–33 18. Benjamin Mason Meier (2010), ‘Global Health Governance and the Contentious Politics of Human Rights: Mainstreaming the Right to Health for Public Health Advancement’, Stanford Journal of International Law, 46 (1), 1–50 19. Benjamin Mason Meier and Larisa M. Mori (2005), ‘The Highest Attainable Standard: Advancing a Collective Human Right to Public Health’, Columbia Human Rights Law Review, 37 (1), Fall, 101–47 20. George P. Smith, II (2005), ‘Human Rights and Bioethics: Formulating a Universal Right to Health, Health Care, or Health Protection?’, Vanderbilt Journal of Transnational Law, 38 (5), November, 1295–321 21. Brigit Toebes (2009), ‘Right to Health and Health Care’, in David P. Forsythe (ed.), Encyclopedia of Human Rights: Volume II, Oxford, UK: Oxford University Press, 365–76 PART IV HEALTH AND INTERNATIONAL ENVIRONMENTAL LAW, INCLUDING ACCESS TO BIOLOGICAL RESOURCES 22. Frederick M. Abbott (2010), ‘An International Legal Framework for the Sharing of Pathogens: Issues and Challenges’, International Centre for Trade and Sustainable Development Programme on Intellectual Property Rights and Sustainable Development, Issue Paper No. 30, Geneva, Switzerland: International Centre for Trade and Sustainable Development, October, i, 1–45 23. Jason Carter (2010), ‘WHO’s Virus is it Anyway? How the World Health Organization can Protect Against Claims of “Viral Sovereignty”’, Georgia Journal of International and Comparative Law: Symposium: International Human Rights and Climate Change, 38 (3), 717–40 24. Stefania Negri (2010), ‘Waterborne Disease Surveillance: The Case for a Closer Interaction between the UNECE Protocol on Water and Health and the International Health Regulations (2005)’, International Community Law Review, 12 (3), 287–302 Index

Read more less

Book SynopsisAs our understanding of genetics increases, its application to criminal justice becomes more significant. This timely book examines the use of genetic information both in criminal investigations and during the trial process. It discusses current scientific understanding and considers some potential legal, ethical and sociological issues with the use of genetic information.The author draws together debates from scientists, ethicists, sociologists and lawyers in order to understand how the criminal justice system currently reacts, and ought to react, to the new challenges presented by genetic evidence. She asks the important question of where priorities should lie: whether with society's desire to be protected from crime, or with an individual's desire to be protected from an unwanted intrusion into his or her genome. Topics include rights of privacy and consent in obtaining DNA samples, evidentiary issues in court, the impact of genetic evidence on punishment theory and sentencing, and genetic discrimination.This book will be of use to criminal and medical law students, along with academics, practitioners and policymakers interested in exploring the various criminal law issues in relation to genetics. It will also be of interest to criminal justice, philosophy, ethics, sociology and psychology students and academics looking explore the legal issues involved in such a topic.Trade Review'Genetics, Crime and Justice is a work of significance. This book enlightens its readers? ? to the debate revolving around human genetics and criminal justice, and provokes thought on? ?how to address the competing interests of society and the individual. Overall, the book presents? ?to its readers, those new to the field or its? ? followers, a comprehensive understanding of the role? ?of genetics in relation to criminality and the judicial system along with the myriad of issues?? surrounding them.?' -- Midhat Farzeen, ?International Social Science Review‘For a reader who is new to the area, Genetics, Crime and Justice provides a useful overview of the legal, ethical and social issues pertaining to the broad area encapsulated by the book. The reader who is familiar with some sections of the book’s scope will likely gain something of interest from the other connected topics Wilson considers. There is significant merit in such a work — one that brings together this diverse but thematically connected body of knowledge.’ -- Current Issues in Criminal JusticeTable of ContentsContents: Preface 1. Introduction, 2. History of Genetics and Criminal Justice, 3. Use of Genetics in Criminal Investigations 4. The “Criminal Gene”, 5. The “Criminal Gene” Argument in the Courts 6. The Impact of a ‘Criminal Gene’ Argument on Punishment Theory 7. Introduction to Ethical Issues 8. Concluding Thoughts Index

Read more less

Book SynopsisThis timely book is an investigation of the highly debated questions: do coroners' recommendations save lives and how often are they implemented? It is the first socio-legal investigation of coroners' recommendations from several countries. Based on an extensive study, it analyses Coroner's Court findings and litigation from Canada, England, Ireland, Australia and Scotland as well as over 2000 New Zealand coroners' recommendations and includes more than 100 interviews and over 40 surveys. The book probes coroners', organisations' and families' experiences of the Coroner's Court in detail and includes substantial quotations from, and discussion of, their experiences. The data analyzed demonstrates that while coronial recommendations can be useful tools for intervention and policy development, coroners' contribution to morbidity and mortality prevention at the population level requires further development. In addition to coroners, lawyers, health practitioners, families, organisations and policy makers, researchers from Law, Medicine and the Social Sciences will find this pioneering volume an important and illuminating resource.Contents: 1. Learning From Death 2. Coronial Jurisdictions 3. Coroners' Recommendations 4. Do Coroners' Recommendations ''Disappear Into A Black Hole?'' 5. The Promise Of Saved Lives: Coroners' Preventive Function 6. Mandatory Responses To Coroners' Recommendations 7. Dying For Change IndexTrade ReviewIn this well-constructed empirical study Moore provides insight on the contemporary role of coronial recommendations. This goes to the heart of the efficacy of the coroner's preventive function. She explores the gap between rhetoric and reality about the role of the coroner as the ombudsman for the dead. Moore's important work fills a serious knowledge gap about coroners' ancient role in advancing riders/recommendations and provides a basis for informed discussion about international coronial law reform and enhanced inquest practice. --Ian Freckelton QC, University of Melbourne and Monash University, AustraliaThis is a fascinating book for anyone interested in the work of coroners. They are often ignored by academics and politicians, but this book shows how coroners can have a crucial role in promoting public health and saving lives. This book could revolutionise the way the work of coroners is understood. --Jonathan Herring, University of Oxford, UKDr Moore's comprehensive book closes a gap in our knowledge about how coroners' recommendations are generated, presented, received and implemented. The research speaks valuable volumes about the relationship between coroners and the societies they serve. By situating the data within a global and historical context, this book covers everything that is essential to understanding coroners' systems. --Dr John D Rutherford, Director of Forensic Pathology, Northern Territory, AustraliaTable of ContentsContents: 1. Learning From Death 2. Coronial Jurisdictions 3. Coroners’ Recommendations 4. Do Coroners’ Recommendations “Disappear Into A Black Hole?” 5. The Promise Of Saved Lives: Coroners’ Preventive Function 6. Mandatory Responses To Coroners’ Recommendations 7. Dying For Change Index

Read more less

Book SynopsisThis timely book provides the first legal and policy analysis of the intellectual property (IP) aspects of a rapidly-growing category of regulatory measures affecting the presentation and advertising of certain health-related goods. The key goods examined are tobacco, alcohol, food, and pharmaceuticals. Chapters focusing on both distinct policy areas and specific country examples serve to unearth the inherent tension emerging between these new measures as well as other categories of public health measures and IP regimes. This book discusses how to balance the legitimate interests of governments to promote human health and the protection and enforcement of IP rights. It also further explores how to amend IP regimes with a view to encouraging companies to produce and market healthier products.Comprehensive and engaging, this book will provide innovative research angles to academics and students in the areas of both health and IP law. Its wealth of examples and analytic style will also prove insightful to legal professionals who advise on issues related to IP and public health as well as policy makers, governments and NGOs.Contributors include: A. Alemanno, J. Blum, E. BonadioI, I. Calboli, I. Carreno, M. Chon, M. Davison, M. Elsmore, M.T. Fujiye, E. Laurenza, A. Marsoof, A. Mitchell, V. VadiTrade Review'A welcome and timely contribution to the increasingly heated debate in the crucial area at the intersection between intellectual property and public health. A must read for practitioners as well as for scholars.' --Marco Ricolfi, University of Turin, Italy'Enrico Bonadio and Alberto Alemanno have brought together a really stimulating and diverse collection of essays on the relationship between intellectual property and public health. The contributors deal effectively with a wide range of issues - from the conflict between trade mark rights and standardised packaging rules (for tobacco and for other products) to the potential manipulation of intellectual property systems to accommodate health goals.' --Jonathan Griffiths, Queen Mary University of London, UKTable of ContentsContents: Introduction: Setting the Scene Alberto Alemanno and Enrico Bonadio PART 1: LEGAL AND POLICY ISSUES 1. Unpacking plain packaging and other standardization requirements in the light of behavioural sciences Alberto Alemanno 2. On the nature of trademark rights: does trademark registration confer positive or negative rights? Enrico Bonadio 3. Trademarks, tobacco, health: brokerage by fundamental rights? Matthew J. Elsmore 4. Trademarks in the pharmaceutical sector: the dynamic between brands, proprietary names and labelling regulations Jeremy Blum 5. The interface between nutrition and health claims and EU trademark law Ignacio Carreño and Eugenia Costanza Laurenza PART II ADJUDICATING THE NEW INTELLECTUAL PROPERTY OF HEALTH 6. Plain packaging of tobacco products and the WTO challenge Mark Davison 7. Challenges in achieving public health objectives through product labelling regulation: reflections on Sri Lankan trademark and constitutional law Althaf Marsoof 8. Tobacco packaging measures affecting intellectual property protection under international investment law: the claims against Uruguay and Australia Andrew D. Mitchell 9. Leveraging certification marks for public health Valentina Vadi PART III REINVENTING THE INTELLECTUAL PROPERTY OF HEALTH 10. Leveraging Certification Marks for Public Health Margaret Chon with Maria Therese Fujiye 11. Terroir and public health: can geographical indications of origin promote ‘healthy’ products? Irene Calboli 12. Patents as a tool to encourage the production of healthier food Enrico Bonadio Index

Read more less

Book SynopsisThis book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-profile competition enforcers, this work provides valuable insider knowledge on the application of competition law and policies to the pharmaceutical industry. Key features include: Extensive commentary on the legislation and the latest case law and administrative precedents in the pharmaceutical sector, at both EU and national level Coverage of various key developments including the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturers In-depth analysis of topics commonly raised in the pharmaceutical sector including: pricing policies, IP life-cycle management, IP licensing and horizontal cooperation agreements Key economic and business perspectives to accompany legal analysis, providing the reader with a rounded view of the subject matter. This book will be a useful resource for lawyers and in-house counsel active in the pharmaceutical sector. The information and analysis provided will prepare readers to take on cases and drive the antitrust review of transactions and agreements within the industry. Researchers, economists and civil servants with an interest in competition law and trade regulation can also benefit from the practical insights provided therein.Trade Review'Impressive and comprehensive. Any practitioner, policy maker or corporate counsel with in an interest in the pharmaceutical industry will find in this book a full overview of the competition and trade issues facing the sector, both from a legal and economic perspective, and covering all the major economies in the world.' --Gunnar Niels, Oxera Consulting LLP, UKTable of ContentsContents: 1. Competition Law and Pharma: An Economic Perspective Benoît Durand 2. Reverse Payments: an EU and U.S. Perspective Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon 3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical Sector Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck 4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical Sector Pierre Moullet 5. Article 102 TFEU: Patent filings as an abuse of dominant position after “AstraZeneca”: the patent / antitrust interface under a new perspective Francisco Hernández 6. Mergers in the Pharmaceutical Sector Pablo Figueroa and Alejandro Guerrero 7. Mergers in the Medical Devices Sector Jan Heithecker 8. Antitrust Practices in Pharmaceutical Public Procurement Antonio Minho López 9. EU Trade Law and Pharmaceuticals Pascale Hecker 10. The Pharmaceutical Sector and Parallel Trade Edurne Navarro Varona and Cristina Caballero 11. Free Movement and Competition in the European Market for Pharmaceuticals Pedro Caro de Sousa 12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical Sector Rais Amils 13. The EU Regulatory Framework for Medical Products for Human Use Marc Martens and Nicolas Carbonnelle 14. Antitrust and the Pharmaceutical Industry in the United States George A. Hay 15. UK Competition and Trade in the Pharma Sector Paula Riedel 16. Competition law and Pharma: China Andrew Foster 17. Competition Law and Pharma: Spain Helmut Brokelmann and Mariarosaria Ganino 18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS Maria Ioannidou and Ioannis Kokkoris 19. Product Hopping: The U.S. Approach Michael A. Carrier 20. Marketing data in the Pharmaceutical Sector: a competition law consideration Pedro Callol Index

Read more less

Book SynopsisThe steady expansion of the European Union's involvement in health over the past 20 years has been accelerated by recent events. This Handbook offers an up-to-date analytical overview of the most important topics in EU health law and policy. It outlines, as far as possible, the direction of travel for each topic and suggests research agendas for the future. Split into five parts, this book brings together international, interdisciplinary contributions to consider the past, present and future of EU health law and policy. The changing membership of the EU could see dramatic changes for EU health law and policy: the contributors consider current developments in the light of past trajectories. The book covers key institutions; policies on people and products; health systems; public health; and the health implications of the EU's external trade policies and laws. Wide-ranging and accessible, this Handbook will appeal to academics and students focussing on EU health law or policy. It will also be of interest to lawyers and policy makers working in or with the EU as well as health managers and NGOs.Contributors include: A. Alemanno, O. Bartlett, L.E. Bishop, E. Brosset, A. de Ruijter, A. den Exter, G. Dussault, M.L. Flear, M. Frischhut, A. Garde, I. Goldner Lang, S.L Greer, M. Guy, T.K. Hervey, H. Jarman, M. Koivusalo, E. Kuhlmann, C. Larsen, A. Mahalatchimy, C.B. Maier, D.S Martinsen, J.V. McHale, N. Mijatovic, E. Pavolini, M. Pilgerstorfer, C. Rieder, C.S. Rusu, W. Sauter, T. Sokol, M.-I. Ungureanu, J.W. van de Gronden, C.A. YoungTrade Review'This book, with contributions from scholars across the Europe and up-to-the-minute coverage of Brexit and its implications, will prove indispensable to anyone interested in health law in the EU, be they within or without Europe.' --(Glenn Cohen, Harvard Law School)'This important new book offers a clear and informative guide to EU health law and policy, but it also does much more than that. The tensions at the heart of the EU's engagement with health are tackled head-on, as are the implications of the Eurozone crisis and Brexit. Through its 19 engaging and lively chapters, this is the best account to date of EU health law and policy's uncomfortable position at the intersection between the promotion of free trade, on the one hand, and public health, on the other.' --(Emily Jackson, London School of Economics, UK)Table of ContentsContents: Foreword Martin McKee Introduction Tamara K. Hervey, Calum Young and Louise E. Bishop Part I History, Scope, Institutions 1. The History and Scope of EU Health Law and Policy Mary Guy and Wolf Sauter 2. Governing EU Health Law and Policy – On Governance and Legislative Politics Dorte Sindbjerg Martinsen 3. Courts and EU Health Law and Policies Clemens M. Rieder 4. Fundamental Rights and EU Health Law and Policy Calum Alasdair Young Part II People and Products 5. EU Law, Policy and Health Professional Mobility Ellen Kuhlmann, Claudia B. Maier, Gilles Dussault, Christa Larsen, Emmanuele Pavolini and Marius-Ionuț Ungureanu 6. European Union Biomedical Research Law and Policy and Citizen Science Mark L. Flear 7. EU Law and Policy on Pharmaceuticals Marketing and Post-Market Control Including Product Liability Marcus Pilgerstorfer 8. EU Law and Policy on New Health Technologies Estelle Brosset and Aurélie Mahalatchimy 9. EU Law and Policy on Human Materials Jean V. McHale and Aurélie Mahalatchimy 10. eHealth Law: The Final Frontier? André den Exter Part III Systems 11. EU Competition Law and Policy and Health Systems Johan W. van de Gronden and Catalin S. Rusu 12. EU Health Law and Policy and the Eurozone Crisis Tomislav Sokol and Nikola Mijatović Part IV Public Health 13. EU Public Health Law and Policy – Communicable Diseases Markus Frischhut and Scott L. Greer 14. EU Public Health Law and Policy – Tobacco Alberto Alemanno 15. EU Public Health Law and Policy - On the Rocks? A Few Sobering Thoughts on the Growing EU Alcohol Problem Oliver Bartlett and Amandine Garde 16. Public Health in European Union Food Law Iris Goldner Lang Part V The External Dimension 17. Trade and Health in the European Union Holly Jarman and Meri Koivusalo 18. The EU’s (Emergent) Global Health Law and Policy Tamara K. Hervey Conclusions 19. The Impediment of Health Laws’ Values in the Constitutional Setting of the EU Anniek de Ruijter Index

Read more less

Book SynopsisThis timely Research Handbook offers significant insights into an understudied subject, bringing together a broad range of socio-legal studies of medicine to help answer complex and interdisciplinary questions about global health - a major challenge of our time. Interdisciplinary chapters explore both how the terrain of medicine can generate new questions about law, regulation and the state, and how the law intersects with health and medicine at every level. Bringing together leading international scholars, the Research Handbook assembles concrete case studies to suggest avenues for further research on socio-legal inquiries, such as the construction of disorders by law, the reparation of injuries, and how race and gender impact justice. The Research Handbook for Socio-Legal Studies of Medicine and Health will be an inspiring read for researchers, academics and graduate students in the fields of health law, socio-legal studies, and gender and sexuality. Contributors include: P. Arcidiácono, J. Barbot, L. Barrera, E. Bernheim, E. Brennan, B. Can, E. Chiarello, É. Cloatre, V. De Greef, N. Dodier, A. Doll, J. Edwards, A.-M. Farrell, J.A. Hamilton, R. Harding, J. Harrington, H.R. Hlavka, C.W.-L. Ho, K. Hoeyer, I. Iyioha, M.-A. Jacob, V. Karavas, A. Kirkland, J. Metzl, D. Moore, C. Morrill, L. Mulcahy, S. Mulla, T. Phillips, J. Piemonte, R. Singh, M. Suchman, M. Thomson, S. WestwoodTrade Review'Wide-ranging and thoughtfully curated, this collection demonstrates just how far the tentacles of healthcare and law extend into social life. Taken together, though, these chapters suggest that the epistemic reach of both law and medicine ultimately exceed their grasp, a conclusion that practitioners and scholars alike will both rue and applaud. With such provocative and carefully researched pieces, this volume is sure to foster a deep rethinking of socio-legal studies of medicine and health. --Carol A. Heimer, Northwestern University, US'Handbooks are often conceived to tie together already-established research fields. With the Research Handbook on Socio-Legal Studies of Medicine and Health, Anna Kirkland and Marie-Andreé Jacob have in fact inaugurated an important new field of study while generously acknowledging its diverse ancestries. I've always thought that STS should instead have been dubbed TLS (technoscience, law and society) whether in studies of health, climate change, migration, inequality or their interconnections. Through an empirically rich set of chapters, handbook contributors perceptively show how socio-legal problems (from femicide to alternative medicine, genetic ancestry testing and gun violence) in highly (bio)medicalized societies throughout the world are always historically and ethnographically situated. This Handbook will be of equal interest to legal scholars, anthropologists, sociologists, bioethicists, philosophers and STS scholars.' --Ayo Wahlberg, University of Copenhagen, Denmark'One of the strengths of socio-legal studies is to show how seemingly mundane and technical practices and artifacts, such as clinical protocols or bureaucratic procedures, shape social realities: how they include and exclude people, and redistribute duties and entitlements. This fantastic volume gives a flavour of the breath and diversity of this lively (inter-)discipline, and also pushes its boundaries into new topics and methodological terrains.' --Barbara Prainsack, University of Vienna, AustriaTable of ContentsContents: Preface Linda Mulcahy 1. Introduction Part I Beyond Healthcare 2. Trapped in limbo: effects of a medical perspective on the education of children with disabilities P. Arcidiácono and L. Barrera 3. Mental disorders and work V. De Greef 4. Challenging capacity: Shifting paradigms of intellectual disability across law, medicine and society R. Harding 5. Genetic Ancestry Tests: Materializing Race and Indigeneity Across Law, Medicine, and Society J.A. Hamilton Part II Ways In Through Terrains 6. Work, facts, and the textual organization of psychiatric involuntary psychiatric admission: Methodological insights from institutional ethnography A. Doll 7. Provincializing the clitoris J. Edwards and M. Thomson 8. The Bearable Lightness of Relationality: Actor-Network-Theory as a Mode of Comparative Law C.W.-L. Ho Part III Ways In Through Models 9. A multi-field logics approach to theorizing relationships between healthcare and criminal justice E. Chiarello and C. Morrill 10. Law and technology in healthcare organizations E. Brennan and M.C. Suchman 11. What role for the state in global health law? A nodal governance perspective from Kenya J. Harrington 12. Substantive Effectiveness, Women’s Health and the Limits of International Human Rights Law I.O. Iyioha Part IV The Meeting Point of Injury 13. Thinking forensically: Law, medicine and the nomos of sexual violence H.R. Hlavka and S. Mulla 14. Proof, probability and the plaintiff: epistemological challenges in the medico-legal field T. Phillips 15. The normative work of victims of medical injuries J. Barbot and N. Dodier 16. Bare death: femicide, forensics and the necropolitics of the corpse R. Singh and D. Moore 17. The (non)denial of torture, human rights and medical expertise B. Can Part V Ethical pluralisms 18. Doctors and global health security: What role for ethics and regulation? A.-M. Farrell 19. Ethics as a form of regulation in relation to data and bodily materials K. Hoeyer 20. Regulating at the boundaries of healthcare: the case of alternative and traditional medicine E. Cloatre 21. Biomedical collective labour: politics, sovereign subjects, and empowerment in biobank research V. Karavas, Vagias Part VI Health as Pretext 22. Justice, power and intersectionality: beyond psychiatry, the social issue in question E. Bernheim 23. Gun violence and mental health: Myths and strategies for socio-legal research J.L. Piemonte and J. Metzl 24. Older lesbian, gay and bisexual people: socio-legal perspectives on healthcare inequalities in later life S. Westwood Index

Read more less

Book SynopsisExamining the ways and extent to which systemic factors affect health outcomes with regard to quality, affordability and access to curative healthcare, this explorative book compares the relative merits of tax-funded Beveridge systems and insurance-based Bismarck systems. The Law and Policy of Healthcare Financing charts and compares healthcare system outcomes throughout 11 countries, from the UK to Colombia. Thematic chapters investigate the economic and legal explanations for the relevant similarities, variations and trends across the globe. Concluding that systemic factors may be less significant than previously believed, this comprehensive book notes that no one system consistently outperforms the others, yet incentives and funding improvements may lift performances across all curative healthcare systems. Analytical and comparative, this book will be of interest to academics working in the fields of health law and health economics. Public authorities including health ministries, policymakers and international health organisations will also find this to be an invaluable resource. Contributors include: F. Bachner, J. Bobek, J. Boertjens, P. Bogetoft, J.M. Burke, F. Dewallens, I. Durand-Zaleski, A. Geissler, C. Góngora Torres, M. Guy, T. Haanperä, J. Janus, S. Jerabkova, L. Lepuschütz, J. Lombard, M. Mikkers, G. O'Nolan, M.J. Perez-Villadoniga, H. Platou, K. Polin, W. Quentin, W. Sauter, V. Shestalova, K.H. Søvig, V. Stephani, A. van den Heever, J. van Manen, J. VermeulenTrade Review'How we pay for our healthcare systems is nothing short of a test of our success as communities and nations: healthcare preserves and promotes human dignity. The balance between rising demands and costs, access for all, and efficiency and quality is pursued in different ways. Studies like this - even though comparable data is scarce - help us see possible better ways forward. The editors have assembled an impressive team, and their comparative research design yields rich insights.' --Tamara Hervey, University of Sheffield, UK'Due to aging populations and technological advancements, countries are facing the challenge of improving healthcare quality, while maintaining access and containing cost. Focusing on the hospital sector, this book discusses how a variety of 11 countries try to meet this challenge. Specific attention is paid to the role of the regulatory framework, market structure, rationing and reimbursement methods. Although no best practice emerges, this book may be very useful for policymakers and anyone else interested in cross-country comparison.' --Frederik T. Schut, Erasmus University Rotterdam, the NetherlandsTable of ContentsContents: Introduction: healthcare financing – an international comparison of models and outcomes Jos Boertjens, Johan van Manen, Misja Mikkers and Wolf Sauter PART I THEMATIC CHAPTERS 1. Explaining America’s spendthrift healthcare system: the enduring effects of public regulation on private competition William M. Sage 2. Effective access to healthcare services abroad under the EU Directive on Cross-Border Patients’ Rights Jarleth M. Burke 3. A legal perspective on tax-based versus insurance-based healthcare systems: comparing England and the Netherlands Jos Boertjens and Mary Guy 4. A theoretical model of the determinants of waiting lists: an application to the Spanish national health system Ana Rodríguez-Álvarez and Maria J. Perez-Villadoniga 5. Financial incentives to change the healthcare landscape: a case study Josine Janus 6. Population-based financing: the future of healthcare? Peter Bogetoft, Misja Mikkers and Victoria Shestalova PART II COUNTRY REPORTS 7. Country report: Austria Julia Bobek, Lena Lepuschütz and Florian Bachner 8. Country report: Belgium Filip Dewallens and Julie Vermeulen 9. Country report: Czech Republic – hospital financing in the Czech Republic Silvie Jerabkova 10. Country report: Colombia – approach to healthcare financing in Colombia and its impact on quality, affordability and competition Catalina Góngora Torres 11. Country report: England Tuomas Haanperä 12. Country report: France Isabelle Durand-Zaleski and Johan van Manen 13. Country report: Germany Katherine Polin, Wilm Quentin, Victor Stephani and Alexander Geissler 14. Country report: Ireland John Lombard and Gerald O’Nolan 15. Country report: the Netherlands Johan van Manen 16. Country report: Norway Karl Harald Søvig and Harald Platou 17. Country report: South Africa Alex van den Heever Index

Read more less

Book Synopsis'The 20th century has been described as the century where governments allowed cigarettes to kill more than 100 million people (i.e. more than the first and second World Wars and the holocaust together). This excellent book is a timely study of the complex, regulatory challenges of e-cigarettes. The review of the scientific evidence relating to electronic cigarettes in Part I - and of international and European regulatory approaches in Part II - of this interdisciplinary, comparative study demonstrates the need for multilevel health governance with due regard to international human rights law, world trade law and health law. European health and risk regulations aim at respecting EU fundamental rights, EU constitutional law principles (e.g. precautionary, subsidiarity and proportionality principles) and legitimate ''constitutional pluralism'' in multilevel health governance. The case-studies of American and Chinese regulations of e-cigarettes in Part III of this book illustrate that ''Chinese state-capitalism'' (e.g. its denial of human rights and constitutional protection of citizens) and Anglo-American neo-liberalism (e.g. its frequent neglect of economic and social rights and international public goods) offer less comprehensive protection of citizen interests, as also confirmed by the current 'US-China trade wars'. Professor Gruszczynski's innovative book succeeds in demonstrating the complexity of ''ordo-liberal'' trade and health regulations of ''market failures'' and ''governance failures'' reconciling civil, political, economic, social and cultural rights and health risks.' - Ernst-Ulrich Petersmann, European University Institute, Italy Combining the insights of leading legal scholars and public health experts, this timely book provides up-to-date analysis of the various legal problems emerging at different levels of governance (international, European and national) in the context of the regulation of e-cigarettes. Expert contributors investigate the possible application of the precautionary and harm reduction principles in this area, examining the legal constraints imposed on states by international and European rules, as well as the regulatory approaches currently in place in selected national jurisdictions. This ground-breaking book offers an interdisciplinary approach to the topic, combining insights from medical, public health and legal perspectives. The Regulation of E-cigarettes will be essential reading for both legal and public health scholars and students. Providing a comprehensive and in-depth assessment of the regulatory solutions applied to e-cigarettes, it will also be a key resource for governmental officials, NGO's and public health advocates. Trade Review'E-cigarettes have radically complicated the landscape of public health aims, agendas, and strategies, especially given the context of the tobacco endgame. They bring multiple layers of scientific, as well as political and regulatory, complexity and disagreement. This carefully-curated volume brings competing voices and perspectives, and at once highlights a crucial variety of considerations at the core of agendas to promote governance for health, and underscores the challenges we find in reason and reasoning within an environment of polarisation and uncertainty.' --John Coggon, University of Bristol, UK'This unique book addresses one of the most important challenges facing the tobacco control community today. Should regulators treat e-cigarettes as a public health threat or rather as a chance to fully eradicate the tobacco epidemic? Gruszczynski's interdisciplinary volume provides a much-needed map that can help answer this question.' --Witold Zatonski, Health Promotion Foundation, Poland'This is a fascinating collection of chapters on the regulation of an uncertain, ambiguous and controversial topic. I highly recommend it to anyone interested in the multitude of perspectives on the topic of e-cigarettes and the law. The volume contains contributions from both advocates of more lenient regimes and contributions propagating a stricter regulation. In addition, it contains chapters from different regions, from the global level as well as from different legal fields.' --Wouter Werner, Vrije Universiteit Amsterdam, the Netherlands and University of Curacao, CuracaoTable of ContentsContents: 1. Introduction: Regulating e-cigarettes in the face of uncertainty Lukasz Gruszczynski Part I Science, regulation and e-cigarettes 2. Divide and conquer? E-cigarettes as a disruptive technology in the history of tobacco control Mateusz Zatoński and Allan M. Brandt 3. Review of the scientific evidence relating to electronic cigarettes: Where do we stand now? Charlie A. Smith, Aleksandra Herbeć and Lion Shahab Part II International and European law perspectives 4. Taming the Schrödinger cat: E-cigarettes under the Framework Convention on Tobacco Control Lukasz Gruszczynski 5. A human rights approach to the regulation of electronic cigarettes Marie Elske C. Gispen and Jacquelyn D. Veraldi 6. A ban on Electronic Nicotine Delivery Systems: Step one into the WTO discrimination analysis Marina Foltea and Bryan Mercurio 7. Regulating e-cigarettes at the EU level Anna Pudło and Lukasz Gruszczynski 8. Vaping and the precautionary principle in EU law Giancarlo A. Ferro and Costanza Nicolosi Part III National law perspectives 9. E-cigarette regulation in Taiwan and China Chuan-Feng Wu, Ching-Fu Lin and Mao-Wei Lo 10. Regulation of e-cigarettes in US law Patricia I. Kovacevic 11. One does not simply sell e-cigarettes in Australia: An overview of Australian e-cigarette regulations Coral Gartner and Marilyn Bromberg Index

Read more less

Book SynopsisThis timely book emphasizes the importance of regulation in enabling and channelling innovation at a time when technology is increasingly embedded in healthcare. It considers the adequacy of current regulatory approaches, identifying apparent gaps, risks and liabilities, and discusses how these might be collectively addressed. The authors present possible solutions that balance the protection and promotion of public trust in healthcare against enabling technological progress and disruptive innovation.Offering both a theoretical and practical approach to challenges at the intersection of healthcare, law and technology, this thought-provoking book explores broad questions of regulation and innovation before analysing contextual applications of these topics. It moves from a wide-ranging consideration of the polycentric and changing nature of health regulation through to a more specific examination of topics including patient consent, the role of device representatives, privacy, artificial intelligence and big data.Providing an international perspective, Technology, Innovation and Healthcare will be a valuable resource for scholars and students of health law, innovation, technology law, law and development and law and society. It will also be of benefit to lawyers, healthcare professionals, technology developers and policy makers, seeking to better integrate technology with healthcare.Trade Review‘The authors summarize the challenges to managing technology in health care, explain how technology impacts care, and offer some exciting and innovative solutions. This is an interesting read for anyone contemplating a career in health care and those already in the field. Many current issues that impact everyday practice, such as data storage, patient privacy, beneficence, fair access to health care, patient autonomy, and professionalism and qualifications of health care providers, are explored. The text includes an excellent discussion of the advantages and disadvantages of technology for health care and addresses the regulations that guide innovative technology use so that laws protect both patients and providers. The role of regulations, national and international, is explained with equal attention to theory and practical rationale. In addition to its appeal for readers preparing for careers in health care, the book will interest policy makers and health care consumers. The text includes an excellent discussion of the advantages and disadvantages of technology for health care and health care consumers. The comprehensive chapter bibliographies will support any reader in delving into more detail as desired. Summing Up: Recommended. All readers.’ -- S C Grossman, CHOICE‘This is an excellent analysis of the relationship between law, innovation, technology, medicine and regulation. The book deals with both generalities at the beginning, then more specific issues – such as AI and data – that are both important now and will become even more so in the future. I can highly recommend it.’ -- José Miola, University of Leeds, UKTable of ContentsContents: PART I SETTING THE SCENE 1. Introduction to Technology, Innovation and Healthcare 2. The essence of innovation PART II INNOVATION AND THE PATIENT 3. Engaging with the voices in the regulatory enterprise in healthcare 4. Consent and innovation – embracing the unknown and empowering the patient 5. The role of medical device representatives in healthcare PART III INNOVATION AS THE FUTURE OF HEALTHCARE 6. When the treatment team involves non-humans: questions of responsibility 7. What does privacy mean in an era of big data? 8. Algorithms, trust and the use of big data in healthcare decisions Final thoughts Bibliography Index

Read more less

Book SynopsisInformed consent is the legal instrument that purports to protect an individual's autonomy and defends against medical arbitrariness. Informed Consent and Health highlights that possession of complete information about all relevant aspects of a proposed treatment is integral to the ability of a patient to make an informed choice. With patient choice at both legislative and judicial levels rising to greater levels of prominence, this timely book examines how the tensions between the rights of patients to make choices and the duties of doctors to provide health care are managed. This illuminating book investigates our evolving understanding of informed consent from a range of comparative and international perspectives, demonstrating the diversity of its interpretations around the world. Chapters offer a nuanced analysis of the problems that impede the understanding and implementation of the concept of informed consent and explore the contemporary challenges that continue to hinder both the patient and the medical community. Containing an in-depth discussion on this fundamental right, this thought-provoking book will be of value to academics and practitioners alike. Providing fascinating insight into new solutions and interpretations, this book will also prove a key resource for clinicians and health care workers. Contributors include: B. Buchner, S.C. Chima, I. Freckelton, R. Fretwell Wilson, N. Glover-Thomas, M. Hartlev, Y. Joly, V.G. Mammadov, G. Marrocco, Y.V. Pavlova, M. Pinkesz, S.I. Pospelova, V.L. Raposo, Y.D. Sergeyev, T. Vansweevelt, M.H. ZawatiTrade Review'Vansweevelt and Glover-Thomas have succeeded in providing a comprehensive picture of the principle of informed consent. This volume shows that despite many different levels of detail, and different interpretations, most countries have rooted the principle of informed consent within their national legislation.' --André den Exter, Erasmus University Rotterdam, the Netherlands'Consent to health care and treatment is a cornerstone of ethical medical practice and any exceptions must be carefully justified. But what exactly is informed consent? This timely book will be of invaluable assistance to practitioners, students and researchers from a range of disciplines, who are interested in understanding what the doctrine of informed consent means across countries with diverse legal systems. This book provides a useful, comparative overview of the scope, interpretation and practical application of informed consent with a view to informing the development of this important doctrine.' --Bernadette McSherry, University of Melbourne, AustraliaTable of ContentsContents: Foreword by Thomas Noguchi ix 1 A general introduction 1 Thierry Vansweevelt and Nicola Glover-Thomas PART I JURISDICTION FROM THE COMMON LAW 2 Informed consent: the Australian perspective 6 Ian Freckelton QC 3 Re-examining the Canadian law of informed consent to medical treatment in the age of informatics 32 Miriam Pinkesz, Gabriel Marrocco, Yann Joly, Ma’n H. Zawati 4 Informed consent: the UK perspective 74 Nicola Glover-Thomas 5 A critique of informed consent in the United States 101 Robin Fretwell Wilson PART II JURISDICTIONS FROM CIVIL LAW 6 Informed consent in Belgium and France 124 Thierry Vansweevelt 7 Informed consent in China and Macao 144 Vera Lúcia Raposo 8 Informed consent in the Nordic countries 163 Mette Hartlev 9 Informed consent in South Africa: a legal, ethical and cross-cultural perspective 183 Sylvester C. Chima PART III JURISDICTIONS IN WHICH THE PRINCIPLE OF INFORMED CONSENT IS ADOPTED IN THE CONSTITUTION 10 Informed consent in Germany 216 Benedikt Buchner 11 Legal regulation of voluntary informed consent in Russia 235 Svetlana I. Pospelova, Yulia V. Pavlova, Yuriy D. Sergeyev, Vugar G. Mammadov 12 Comparative conclusions: towards a global vision of informed consent? 256 Thierry Vansweevelt and Nicola Glover-Thomas Index 271

Read more less

Book SynopsisThis timely book investigates the issue of counterfeit and falsified medicines (CFM) in the EU, identifying that this is a problem that lies at the intersection of three spheres of law - medicine, intellectual property (IP), and criminal law. The book highlights key issues such as infiltration of the legal supply chain and the involvement of organised crime, analysing relevant EU law and demonstrating the challenges of CFM.Using examples from several case studies, Vishv Priya Kohli reveals the gaps in the current legal framework, underlining the particular difficulties created by the interplay between different areas of law as well as the lack of criminal penalties. The author explores areas where improvements have already been made, in particular through the Falsified Medicines Directive, and articulates a number of recommendations to fill in the gaps, for example by harmonizing criminal law and building synergies within law enforcement.Counterfeit and Falsified Medicines in the EU will be of great interest to academics and students in IP, health and medical law, and criminal law in the EU. It will also prove valuable for practitioners and policymakers working in and with enforcement authorities in the EU, as well as those working in the medical field itself.Trade Review‘The problem of counterfeit medicines, while having its political, economic, medical and social dimension, is also a legal problem. This work is a study of the legal side of counterfeiting from the EU perspective. It provides a comprehensive analysis of the current EU regulatory framework, including medical law, IP law and criminal law. In addition to that, the book also offers detailed case studies of some of the most exciting counterfeiting examples explaining how they were dealt with. A timely and useful work.’ -- Andrej Savin, Copenhagen Business School, DenmarkTable of ContentsContents: Preface 1. Introduction to counterfeit and falsified medicines 2. Counterfeit and falsified medicines – case studies 3. Medicines law – an analysis of the Falsified Medicines Directive 4. IP law – an analysis of the Enforcement Directive and the Customs Regulation 5. Criminal law and counterfeit and falsified medicines 6. Conclusion and recommendations Index

Read more less

Book SynopsisThis timely book offers a fresh perspective on how to effectively address the issue of unequal access to healthcare. It analyses the human right to health from the underexplored legal principle of solidarity, proposing a new understanding of the positive obligations inherent in the right to health.Combining human rights law, public health and social theory, Eduardo Arenas Catalán demonstrates that when interpreted in line with the principle of solidarity, the right to health should be viewed as a non-commercial right. Arenas Catalán argues that the right to health's functions are to challenge the commodification of healthcare and to advance free-of-charge public healthcare services. Moreover, through a critical analysis of classical jurisprudence concerning the right to health, the book delivers a searing indictment of the effects of neoliberal capitalism and commercialization on human rights.This thought-provoking book will be of interest to scholars and students of law, in particular international human rights law, public international law and legal theory, as well as social and public health researchers and students. Policy makers and legal practitioners will also find its original analysis of solidarity in the context of human rights and the law useful.Trade Review'In this compelling study of the human right to health, Eduardo Arenas Catalán moves beyond a common focus on access to care enforced by judges, indicting failures to challenge commercialization of life itself in our time. The results convincingly situate extant doctrine and jurisprudence, whether from international law and national settings, within an ambitious agenda of making social rights more genuinely solidaristic.' -- Samuel Moyn, Yale University, USTable of ContentsContents: Preface 1. Human rights and commercialization 2. The predominant interpretation of the right to health 3. Solidarity and health 4. The right to health as a social right 5. The adjudication of the right to health 6. Solidarity and the right to health: provision and financing of healthcare 7. Conclusions Bibliography Index

Read more less

Book SynopsisElgar Advanced Introductions are stimulating and thoughtful introductions to major fields in the social sciences, business and law, expertly written by the world’s leading scholars. Designed to be accessible yet rigorous, they offer concise and lucid surveys of the substantive and policy issues associated with discrete subject areas.Written by esteemed legal scholar Michael L. Perlin, this indispensable Advanced Introduction examines the long-standing but ever-dynamic relationship between law and mental health. The author discusses and contextualises how the law, primarily in the United States but also in other countries, treats mental health, intellectual disabilities, and mental incapacity, giving examples of how issues such as the rights of patients, the death penalty and the insanity defense permeate constitutional, civil, and criminal matters, and indeed the general practice of law.Key features include: unpacks key US Supreme Court decisions to focus on the issues that have been most significant in the development of the field explains the distortion of this area of law by biased and stereotypical social attitudes including sanism examines lesser-known cases that illuminate judicial attitudes, helping readers to better understand likely future developments in mental health law. Offering an insightful introduction to this field, the Advanced Introduction to Mental Health Law is an invaluable resource for students and newly qualified lawyers, and will appeal not only to those looking to understand the law in the United States, but how this contributes to the development of the field as a whole.Trade Review’Michael Perlin is widely acknowledged as one of the leading voices in mental disability law, with an unequalled breadth of understanding. That breadth is on full display in his latest book, which spans civil and criminal law, as well as international law. Perlin’s unique lens on the theory and practice of mental health law is on full display in this work, which powerfully summarizes a lifetime of work in the field of mental health law.’ -- - Susan Stefan, Committee for Public Counsel Service, Massachusetts, US’Michael Perlin has authored a(nother) remarkable text. This Advanced Introduction to Mental Health Law presents a fresh, engaging overview of mental disability law, with detailed coverage of a range of issues relevant to mental disability as it pertains to civil and criminal law, and set within the context of relevant case law and insightful commentary. This book is an excellent resource for anyone involved at the interface of mental health and legal systems, from graduate students learning about law and mental health to advanced practitioners responsible for maintaining competent practice.’ -- - Patricia A. Zapf, Ph.D, Palo Alto University, US’Nobody knows more about mental health law than Michael Perlin, and Advanced Introduction to Mental Health Law is his magnum opus. His other books may be more comprehensive, but this book covers complicated topics with astonishing clarity. This book is a must read for attorneys, forensic psychologists and psychiatrists, judges, and people with lived experience who routinely deal with mental disabilities in legal contexts.’ -- - Joel A. Dvoskin, Ph.D., ABPP (Forensic), University of Arizona, College of Medicine, US’This book is a professor’s dream, packaging the vast subject of mental health law into the most-user-friendly companion. Called an “Advanced Introduction” it is both, as Professor Perlin’s masterly synthesis is a reference work for both teachers and students of mental health law. The inclusion of history, case law, and therapeutic jurisprudence puts his brilliance on display. The text is easily accessible and the references provide a roadmap to the universe of the intersection of law and mental health.’ -- - Kenneth J. Weiss, University of Pennsylvania, US’Michael L. Perlin’s excellent book, Advanced Introduction to Mental Health Law, is aptly named - not because it is difficult, but because it is usefully thorough. In its chapter on the right to counsel in civil commitment proceedings, for example, Perlin details the various ways state statutes provide for counsel and whether they are silent or detailed on the specific roles expected of lawyers.Perlin also looks at mental health law through various “filters” that have been detrimental to the administration of the law - such as “sanism” and pretextual decision-making. In response, Perlin’s work is driven by a positive filter: the “potentially redemptive significance of the school of thought known as therapeutic jurisprudence.” This is a wonderful achievement.’ -- David B. Wexler, University of Puerto Rico and University of Arizona, US’Professor Michael L. Perlin’s modestly titled Advanced Introduction to Mental Health Law provides the royal road for mental health clinicians and attorneys in all stages of experience, from neophyte to expert to travel ethically and effectively through the otherwise foreboding dark woods of civil and mental health disability law. Whether a student or an experienced practitioner, each chapter enlightens and encourages a deeper yet ever more practical understanding. Perlin’s readable, reasonable style is lyrical and lawyerly, all the more apt for a field where one feels with apologies to Bob Dylan, “there is something happening here” alongside “Oh my G-d, am I all alone”.Inspired by Professor Perlin’s vital contributions to mental health law over the decades to such questions as what is the line between “sanity” and “sanism” the book is both timeless and timely and of both very special and very general interest.’ -- - Harold J. Bursztajn, Harvard Medical School, USTable of ContentsContents: 1. Introduction to the Advanced Introduction to Mental Health Law 2. Some jurisprudential filters 3. Counsel and judges 4. Civil commitment law 5. Institutional rights 6. Rights of persons with mental disabilities in community settings 7. Between civil and criminal mental disability law 8. Criminal incompetencies 9. The insanity defense 10. Access to experts, sentencing, and correctional treatment issues 11. The death penalty Bibliography Index

Read more less

Book SynopsisElgar Advanced Introductions are stimulating and thoughtful introductions to major fields in the social sciences, business and law, expertly written by the world’s leading scholars. Designed to be accessible yet rigorous, they offer concise and lucid surveys of the substantive and policy issues associated with discrete subject areas.Written by esteemed legal scholar Michael L. Perlin, this indispensable Advanced Introduction examines the long-standing but ever-dynamic relationship between law and mental health. The author discusses and contextualises how the law, primarily in the United States but also in other countries, treats mental health, intellectual disabilities, and mental incapacity, giving examples of how issues such as the rights of patients, the death penalty and the insanity defense permeate constitutional, civil, and criminal matters, and indeed the general practice of law.Key features include: unpacks key US Supreme Court decisions to focus on the issues that have been most significant in the development of the field explains the distortion of this area of law by biased and stereotypical social attitudes including sanism examines lesser-known cases that illuminate judicial attitudes, helping readers to better understand likely future developments in mental health law. Offering an insightful introduction to this field, the Advanced Introduction to Mental Health Law is an invaluable resource for students and newly qualified lawyers, and will appeal not only to those looking to understand the law in the United States, but how this contributes to the development of the field as a whole.Trade Review’Michael Perlin is widely acknowledged as one of the leading voices in mental disability law, with an unequalled breadth of understanding. That breadth is on full display in his latest book, which spans civil and criminal law, as well as international law. Perlin’s unique lens on the theory and practice of mental health law is on full display in this work, which powerfully summarizes a lifetime of work in the field of mental health law.’ -- - Susan Stefan, Committee for Public Counsel Service, Massachusetts, US’Michael Perlin has authored a(nother) remarkable text. This Advanced Introduction to Mental Health Law presents a fresh, engaging overview of mental disability law, with detailed coverage of a range of issues relevant to mental disability as it pertains to civil and criminal law, and set within the context of relevant case law and insightful commentary. This book is an excellent resource for anyone involved at the interface of mental health and legal systems, from graduate students learning about law and mental health to advanced practitioners responsible for maintaining competent practice.’ -- - Patricia A. Zapf, Ph.D, Palo Alto University, US’Nobody knows more about mental health law than Michael Perlin, and Advanced Introduction to Mental Health Law is his magnum opus. His other books may be more comprehensive, but this book covers complicated topics with astonishing clarity. This book is a must read for attorneys, forensic psychologists and psychiatrists, judges, and people with lived experience who routinely deal with mental disabilities in legal contexts.’ -- - Joel A. Dvoskin, Ph.D., ABPP (Forensic), University of Arizona, College of Medicine, US’This book is a professor’s dream, packaging the vast subject of mental health law into the most-user-friendly companion. Called an “Advanced Introduction” it is both, as Professor Perlin’s masterly synthesis is a reference work for both teachers and students of mental health law. The inclusion of history, case law, and therapeutic jurisprudence puts his brilliance on display. The text is easily accessible and the references provide a roadmap to the universe of the intersection of law and mental health.’ -- - Kenneth J. Weiss, University of Pennsylvania, US’Michael L. Perlin’s excellent book, Advanced Introduction to Mental Health Law, is aptly named - not because it is difficult, but because it is usefully thorough. In its chapter on the right to counsel in civil commitment proceedings, for example, Perlin details the various ways state statutes provide for counsel and whether they are silent or detailed on the specific roles expected of lawyers.Perlin also looks at mental health law through various “filters” that have been detrimental to the administration of the law - such as “sanism” and pretextual decision-making. In response, Perlin’s work is driven by a positive filter: the “potentially redemptive significance of the school of thought known as therapeutic jurisprudence.” This is a wonderful achievement.’ -- David B. Wexler, University of Puerto Rico and University of Arizona, US’Professor Michael L. Perlin’s modestly titled Advanced Introduction to Mental Health Law provides the royal road for mental health clinicians and attorneys in all stages of experience, from neophyte to expert to travel ethically and effectively through the otherwise foreboding dark woods of civil and mental health disability law. Whether a student or an experienced practitioner, each chapter enlightens and encourages a deeper yet ever more practical understanding. Perlin’s readable, reasonable style is lyrical and lawyerly, all the more apt for a field where one feels with apologies to Bob Dylan, “there is something happening here” alongside “Oh my G-d, am I all alone”.Inspired by Professor Perlin’s vital contributions to mental health law over the decades to such questions as what is the line between “sanity” and “sanism” the book is both timeless and timely and of both very special and very general interest.’ -- - Harold J. Bursztajn, Harvard Medical School, USTable of ContentsContents: 1. Introduction to the Advanced Introduction to Mental Health Law 2. Some jurisprudential filters 3. Counsel and judges 4. Civil commitment law 5. Institutional rights 6. Rights of persons with mental disabilities in community settings 7. Between civil and criminal mental disability law 8. Criminal incompetencies 9. The insanity defense 10. Access to experts, sentencing, and correctional treatment issues 11. The death penalty Bibliography Index

Read more less

Book SynopsisPresenting detailed analysis of the industrialization and commercialization of pharmaceutical patents in China, this timely book explores a range of related topics including a comparison of the ideal and existing state of the pharmaceutical market and patent industrialization. It argues that the core purpose of the industrialization of pharmaceutical patents is to promote the development of the local pharmaceutical industry whist also protecting society's right to safe and effective medication.Chapters examine the special application issues of patent law in relation to the field of pharmaceuticals, compare the Chinese and American legal systems and their approach to pharmaceutical patents, and provide in depth political and legal analysis of the industry. James Hou suggests methods by which the Chinese legal system can seek to improve its governance of pharmaceutical patents and balance the conflicts of interest arising between new drug developers, established drug manufacturers and the end users.Featuring comprehensive coverage of patents in the Chinese pharmaceutical industry, this book will be a key resource for scholars and students of commercial, pharmaceutical and intellectual property law, whilst also being of interest to industry talents discovering the potential of their own innovations.Table of ContentsContents: Forward Preface Introduction 1. On the importance of patents in pharmaceutical industry development 2. Pharmaceutical markets and patents: Idealized, and in practice 3. Comparison of Chinese and American legal systems on pharmaceutical patents 4. Patent law issues unique to pharmaceuticals 5. Improvement of China’s pharmaceutical patent system 6. Law and policy analysis of China’s pharmaceutical patent industrialization 7. Conclusion

Read more less

Book SynopsisThis book critically considers the dynamic relationship between clinical guidelines and medical negligence litigation, arguing that a balance must be struck between blinkered reliance on guidelines and casual disregard. It explores connections between academic law and professional practice, bringing together an array of perspectives which reveal that although guidelines may not be dispositive, they nonetheless play an important role in medical negligence law.The chapters provide compelling insights from academics, lawyers, barristers, doctors and healthcare professionals into the use of guidelines in determining the legal standard for breach of duty, thereby contributing to a holistic understanding of guideline usage in this area of law. Sociological considerations along with empirical findings are used to underpin these concepts. While focusing on the UK, contributors draw upon international law including that from the United States, South Africa, the Netherlands and other countries. Based on this analysis the conclusion offers a theoretical framework for practical application illustrated by a case-based discourse.This book makes a significant contribution to the knowledge base in the subject area. It is an essential read for legal academics and lawyers working in medical and health law, as well as for doctors and other healthcare professionals. It will be a key reference point for medical regulators, health organisation policymakers and clinical governance teams.Trade Review‘The most detailed and rich consideration of the legal status of national and local clinical guidelines available. The volume tackles fundamental legal and ethical questions, concerning the role of healthcare instruments which claim a basis in robust development processes and scientific data: do guidelines legitimately underpin ‘guidance’ or ‘instructions’; how do - and should - they influence courts, in differing jurisdictions, when deciding legal standards of care; and what are the legal implications of practitioners’ adhering to, or departing from, clinical guidelines? In keeping with a governance tool that has ramified throughout the medical world, the editors, Jo and Ash Samanta, recognise the extraordinary global reach of guidelines and have assembled an array of international scholars and legal and medical analysts, to critically interrogate this trans-national legal nexus. Teeming with analysis of the key legal principles and cases, this collection offers the most expansive and authoritative treatment of the subject.’ -- Brian Hurwitz, King’s College London, UK'This is a timely collection, written by experts in the field, that provides real insight into legal and ethical issues around clinical guidelines and the law of negligence. The book succeeds in its aim of bringing together different perspectives to create an overview where previously there were discrete and narrow silos of research. I can thoroughly recommend it.' -- Jose Miola, University of Leeds, UKTable of ContentsContents: Foreword x Preface xii Introduction: clinical guidelines and the law of medical negligence 1 Ash Samanta and Jo Samanta 1 The early usage of clinical guidelines in medical negligence litigation: an Anglo-American perspective 12 Ash Samanta and Jo Samanta 2 Reliance on clinical guidelines in contemporary negligence litigation in the UK: influential or determinative? 52 Rob Heywood 3 Medical guidelines in South African courts: exploring their role in medical negligence matters 80 Camilla Pickles 4 Fitness to practice tribunals in the UK and the Netherlands: the construction of (para)medical competence and the use of evidence-based guidelines 112 Friso Johannes Jansen 5 The interface between clinical guidelines and health care ethics 143 Marwan Habiba 6 A barrister’s experience of the use of clinical guidelines in clinical negligence litigation 175 Pritesh Rathod 7 The role of guidelines and protocols in clinical negligence litigation: a solicitor’s viewpoint 199 Laurence Vick 8 Evidence-based medicine, clinical guidelines, trustworthiness and safe care in anaesthetics 228 Rebecca Parrott and Debashish Dutta 9 Clinical guidelines in trauma and orthopaedic surgery 252 Simon Britten 10 A global perspective of the use of clinical guidelines in medical negligence litigation 281 Jo Samanta and Ash Samanta Conclusion: clinical guidelines and the law of medical negligence 322 Ash Samanta and Jo Samanta Index 341

Read more less

Book SynopsisThis forward-looking book provides an in-depth analysis of the major transformations of the right to health in Latin America over the past decades, marked by the turn towards the pharmaceuticalisation of health care. Everaldo Lamprea-Montealegre investigates how health-based litigation has deepened inequalities in the global South, exploring the practices of key actors that are reclaiming the right to health in the region. Taking a deep dive into the health care systems of Brazil and Colombia, Local Maladies, Global Remedies illustrates how transnational pharmaceutical companies are influencing the litigation of health rights, from moulding doctors’ preferences for branded drugs to controlling the availability of cheaper generics and bio-similars. The book deploys a wide range of theoretical perspectives and insights from socio-legal literature to map out the practices of stakeholders that are reclaiming the right to health in Latin America. Its concluding remarks propose a set of remedies to help alleviate the challenges faced by global South countries when trying to guarantee their population’s right to health, ultimately calling for a major shift of decision-making responsibilities from a local to a global level. The wide-ranging, interdisciplinary scope of this cutting-edge book will benefit scholars, practitioners, policymakers, and students operating at the intersections between socio-legal studies, sociology, health anthropology, public health, globalisation, and human rights.Trade Review‘Everaldo Lamprea’s book Local Maladies, Global Remedies: Reclaiming the Right to Health in Latin America is an important and insightful contribution to the literature on the right to health. The book documents the background to the crisis caused by the pharmaceutization of the right to health in Colombia and Brazil and the resulting litigation epidemics in those countries. Significantly the book shows the limitations of an individualized approach to the right to health and to make the right to health more appropriate in the pandemic context calls for supplementing the conceptualization of the right to health with a polycentric regime or responsibilities incorporating a wide array of interconnected stakeholders and mediating institutions.’ -- Audrey R. Chapman, University of Connecticut, US‘The book Local Maladies, Global Remedies: Reclaiming the Right to Health in Latin America by Everaldo Lamprea-Montealegre presents a fascinating analysis of the current problems and paradoxes regarding right to health access in the global South. The sophisticated framework proposed to interpret these problems and paradoxes (what the author calls the political economy of the right to health) meticulously unpacks an array of actors and interests present in right to health cases, particularly in the cases of Colombia and Brazil. As such, it provides a crucial contribution for policy makers, researchers, and public health academics.’ -- Helena Alviar García, Sciences Po École de droit, FranceTable of ContentsContents: The right to health in action: an introduction PART I THE TRANSFORMATIONS OF THE RIGHT TO HEALTH 1. The elusive search for the minimum core of the right to health 2. The political economy of the right to health: a terrain for contestation 3. The judicialization of health care in the Global South PART II LOCAL MALADIES: THE EPIDEMIC OF THE RIGHT TO HEALTH IN BRAZIL AND COLOMBIA 4. Health system reform and the rise of litigiousness in Brazil and Colombia 5. The HIV/AIDS pandemic and the plight of vulnerable patients: understanding the first wave of litigiousness in Brazil and Colombia (1990–2000) 6. Riding a second wave (2000–2020): the downstream approach and the rise of “high-cost patients” 7. A case study of patients’ organizations: between good causes and hidden clients 8. Stopping a litigation epidemic: lessons from Colombia and Brazil’s highest courts The promise of the right to health, and why we have to keep it: closing reflections Bibliography Index

Read more less

Book Synopsis

Read more less

Book SynopsisDespite recurring efforts, a gap exists across a variety of contexts between the protection of patients’ safety in theory and in practice. This timely Research Handbook highlights these critical issues and suggests both legal and policy changes are necessary to better protect patients’ safety. Multidisciplinary in nature, this Research Handbook features contributions from eminent academics, policy makers and medical practitioners from the Global North and South, discussing the essential facets concerning patient safety and the law. It highlights how the role of legislation and case law has the potential to influence, both positively and negatively, medical practice and the quality of care. Chapters explore patient safety and the global health agenda; physiotherapy; ‘non-therapeutic’ clinical research with children; patient safety awareness in healthcare education; and the increasing use of robotics and artificial intelligence in healthcare.Outlining a wide range of international perspectives on patient safety and the law, this Research Handbook will appeal to academics and researchers specialising in health and medical law, human rights, and healthcare regulation. It will also serve as a valuable resource for legal and medical practitioners alike, as well as clinicians and professionals working in healthcare governance.Trade Review‘An essential guide to assessing the systemic failures that put patient safety and well-being at risk, the Research Handbook on Patient Safety and the Law explores the challenges to improved patient care using multi-disciplinary and international perspectives. The book provides an in-depth exploration of the legal, ethical, and policy issues at work and offers pragmatic responses to the complex array of factors that endanger patients.’ -- Barbara A. Reich, Professor of Law, Western New England University School of Law, US‘“First do no harm”, we're told. But in the legal literature patient safety is very far from the first consideration. This fascinating and comprehensive Research Handbook redresses the imbalance. Essential reading for everyone concerned with medical law, ethics and governance.’ -- Charles Foster, University of Oxford, UKTable of ContentsContents: 1 Patient safety and the law: an introduction 1 John Tingle, Caterina Milo, Gladys Msiska, and Ross Millar 2 The need for more conceptual underpinning in NHS patient safety and clinical negligence policy development 10 John Tingle 3 The law and ethics of informed consent after Montgomery and the safeguard of patients’ safety 22 Caterina Milo 4 ‘Non-therapeutic’ clinical research with children: responsibility in the balance? 37 Amber Dar 5 Balancing on a knife edge: patient safety and autonomy in the psychiatric context 56 Mollie E. L. Cornell 6 The role of tort law in protecting patient safety and autonomy in Australia 74 Barbara McDonald 7 Healthcare in conflict: legally protected, physically at risk 90 Emma J. Breeze 8 Does legalising abortion reduce deaths from unsafe abortion? Experiences in sub-Saharan Africa 108 Calum Miller 9 Physiotherapy in the UK: the second victim in a perfect storm? 125 Sue Greenhalgh, James Selfe, Laura Finucane, and Gillian Yeowell 10 Patient safety at the end of life: the role and limits of the law in England and Wales 141 Adam McCann 11 The ‘patient-friendly’ medical injury liability rules in Germany: implications for patient safety? 165 Marc Stauch 12 Patient safety in Germany 177 Dagmar Luettel, Victoria Klemm, and Reinhard Strametz 13 Patient safety, global governance, and the right to health in integrated primary health care 193 Jonathan Gorry, Linda Gibson, Denis Joseph Bukenya, Pauline Odeyemi, and Michael Obeng Brown 14 Patient safety and the global health agenda 206 Paulo Sousa, Ana Catarina Rodrigues, and José Pedro Teixeira 15 Patient safety in Uruguay 221 Homero Bagnulo, Alejandro Castello, and Carlos Vivas 16 Pregnancy and childbirth risks: clinical and legal perspectives 237 Pedro Melo, Abdea Coomarasamy, and Arri Coomarasamy 17 Patient safety challenges and practical ethical legal issues in low- and middle-income countries 257 Gladys Msiska, Evelyn Chilemba, Martha Kamanga, Chisomo Mulenga, Annie Namathanga, Patrick Mapulanga, and Abigail Kazembe 18 Child safety in developing countries 278 Felistas Chiundira and Pempho Katanga 19 Patient safety consciousness in healthcare education 297 Gladys Msiska, Gervasio Nyaka, Wanangwa Chikazinga, and Patricia Katowa-Mukwato 20 Developing patient safety standards 314 Helen Hughes 21 Dr Robot: robotics and AI in healthcare 336 Angela Eggleton 22 Patient safety and the law: a thematic review and assessment of future options 369 Ross Millar Index 377

Read more less

Book SynopsisThis title contains one or more Open Access chapters.This innovative book provides an in-depth exploration of the legal, regulatory and ethical challenges posed by the practice of uterus transplantation (UTx) from a wide range of international perspectives.

Read more less

Book SynopsisThis comprehensive book provides a detailed survey and practical examination of a wide range of legal and regulatory topics in HealthTech. Combining the insights of leading healthcare experts from around the world, chapters first examine the key characteristics, use cases and regulation in the field, before turning to the development and potential applications of cutting-edge technologies in healthcare. The book also addresses the main issues involved in setting up and running a HealthTech business, highlighting the vital role this will play in developing the technologies and skill sets required for the future of the sector.Key features include: analysis of the impact of emerging innovations on the accessibility, efficiency and quality of healthcare and its effects on healthcare providers examination of artificial intelligence, blockchain and digital identity applications in healthcare, alongside associated regulatory challenges guidance on the financial requirements of healthcare start-ups at different stages of growth and various collaboration and partnership models in the HealthTech market discussion of the major regulatory questions affecting the HealthTech industry, from data protection, public procurement and product liability, to the regulation of medical devices, intellectual property and advertising. HealthTech: Law and Regulation will be an invaluable resource for both in-house lawyers in the healthcare and pharmaceutical sectors, as well as those working for law firms practising in these areas. It will also be of interest to academics and students teaching or researching in healthcare law.Trade Review‘Healthtech: Law and Regulation makes an important contribution in the field of medical technology industry. It will be an invaluable resource for regulators and researchers looking to address the challenges produced by the technological advancement.’ -- Fatima Kanij, Law in Context'The act of providing health-related care is experiencing a technology-enabled consumer revolution that has only compounded in the time of this rarely experienced pandemic. In order to understand and thrive in these changing yet exciting digital times, you need knowledge, a reference, a guide and a plan for excelling. This collection of all-encompassing topics around digital health technology is a must read and can assist in creating a True North for those bold passionate individuals and businesses that will change the world and spark innovation in how we deliver and receive health-related care.' --Samir Batra, BAHA Enterprises, US‘A valuable and timely addition to the literature, this book considers some of the most pressing issues facing those who practise, or are generally interested in, this rapidly developing field of law. Emerging technology offers unprecedented opportunities to transform the way healthcare is delivered, saving time, money and resources while also improving healthcare and wellness outcomes. But new healthtech also raises novel legal and regulatory challenges that we must grapple with if we are to assuage fundamental societal concerns around data privacy and ownership; avoiding designed-in biases; equitable access to healthcare; and how to innovate at pace without compromising end-user safety. Dr. Madir and her respected team of contributors traverse both the UK and international landscape with authority and insight.’ -- Daniel Morris, Bevan Brittan LLP, UK'A valuable and timely addition to the literature, this book considers some of the most pressing issues facing those who practise, or are generally interested in, this rapidly developing field of law. Emerging technology offers unprecedented opportunities to transform the way healthcare is delivered, saving time, money and resources while also improving healthcare and wellness outcomes. But new healthtech also raises novel legal and regulatory challenges that we must grapple with if we are to assuage fundamental societal concerns around data privacy and ownership; avoiding designed-in biases; equitable access to healthcare; and how to innovate at pace without compromising end-user safety. Dr. Madir and her respected team of contributors traverse both the UK and international landscape with authority and insight.' --Daniel Morris, Bevan Brittan LLP, UK'HealthTech provides a comprehensive accounting of the myriad legal issues that might affect health technology in practice, from medical devices to patient care, clinical trials and patient rights. The authors do an exceptional job explaining the future of healthcare for artificial intelligence and telehealth. If you are interested in the technology of healthcare, this book provides an excellent primer on the key issues that might affect your organization.' --Charlotte Tschider, Loyola University School of Law, US‘As data-driven and innovative health technologies will increasingly determine the nature of integrated health services while necessarily demanding transnational cooperation, this book is on the spot: a profound cross-border analysis of key use cases in healthcare technology and regulatory frameworks covering current and future core issues. A must read for all forward-looking minds in the healthcare sector.’ -- Fabian Raddatz, Labor Berlin, Germany‘This is a book which covers a wide range of topics relevant to HealthTech – from AI to data protection and from blockchain to medical devices regulation. It is ambitious in its vision, not shying away from covering areas which are still in a state of change and assessing the opportunities of HealthTech whilst also taking a cool eyed view of challenges such as slow procurement processes and the interoperability with legacy systems, which will meet with recognition by anyone who has spent time working in this sector. Its breadth and up-to-date content will make it a book to be kept at hand by lawyers, academics, investors, strategists, healthcare providers and suppliers alike. The book uses the example of Fintech as a thread running throughout – as a recent disruptor technology in a highly regulated sector this is a very valuable comparator. Lastly, the chapter on emerging markets strikes a particular chord in these times of global pandemic, where the interconnectedness of global healthcare systems has never been more apparent and the value of HealthTech tools (for example in track and trace apps) have shown themselves to be of huge significance in management of disease at a local and global scale.’ -- Louise Fullwood, Pinsent Masons LLP, UKTable of ContentsContents: Preface xvii 1. Using technology to deliver health services 1 Jelena Madir PART I REGULATION AND GOVERNANCE OF HEALTHTECH 2. Data protection, information security and international data transfers: a practical guide through key provisions and compliance tools 24 Tom Chakraborti 3. Healthcare technology regulation in the EU and the UK: from medical devices to intellectual property and advertising 53 Alison Dennis 4. Healthcare technology regulation in the US 80 Matthew DeNoncour 5. Product liability: compliance and safety issues 114 Annabelle Bruyndonckx, Vladimir Murovec and Michael Bulckaert PART II FRONTIER TECHNOLOGIES AND MARKETS 6. Artificial intelligence in healthcare 14 Roland Wiring 7. The role of digital ID in healthcare 167 Emeka Chukwu 8. Blockchain opportunities in healthcare 193 Jelena Madir 9. Technology and healthcare opportunities in emerging markets 218 Jane Thomason and Nichola Cooper PART III HEALTHTECH BUSINESSES 10. Financing healthcare start-ups 246 Stephen Tainsh 11. Collaboration and partnership structures in HealthTech 270 Simonetta Giordano, Frédérique Potin and Sharon Cohen 12. Procurement considerations for the acquisition of HealthTech products 303 Patrick Parkin 13. The impact of the European Medical Device Regulations on the development and use of mHealth apps in Europe 329 Trix Mulder 14. Telemedicine: opportunities and challenges – a US perspective 354 Richard Cheng and Barrett Robin 15. What skills will be required of healthcare professionals in the future? 374 C. Donald Combs Glossary of key terms 398 Index 403

Read more less

Book SynopsisIndia's 2005 adoption of a TRIPS-consistent patent regime will reveal whether Indian generic pharmaceuticals companies will continue to supply essential drugs for developing nations such as Thailand, who are reliant on India for the supply of cheap medicines. Patent Rights in Pharmaceuticals in Developing Countries investigates the public policy and public health implications of pharmaceutical patenting in countries such as India and Thailand. The book engages with a broad range of new case studies, providing a detailed examination of options for the resolution of access-to-medicine issues at global, national and local levels. In addition, the book reflects the significant progress in international and national patent law and in international policymaking in this area. Broadly accessible, the work will appeal to advanced undergraduate and postgraduate students, as well as researchers and academics in fields such as intellectual property law, public health, industrial economics, development studies and political science. National policymakers and government officials, as well as professionals based in international organizations and pharmaceutical industries, will also find this exciting work of great interest.Trade Review‘Dr Kuanpoth’s book is an erudite and constructive contribution to the debate on patents and public health. The book’s focus on India and Thailand, both of which have sought actively to balance patent rights with public health goals, provides some valuable findings that should lead to more sensitive intellectual property policymaking in the developing and developed worlds.’ -- Graham Dutfield, University of Leeds, UKTable of ContentsContents: Introduction 1. Patent System Overview 2. Patents and their International Application 3. Patent Rules and Procedures: Indian Law 4. Patent Rules and Procedures: Thai Law 5. Patent Protection for Pharmaceuticals: The Case of India 6. Patent Protection for Pharmaceuticals: The Case of Thailand 7. Patents and Access to Essential Medicines 8. Comparative Analysis Bibliography Index

Read more less

Book SynopsisThis up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights. With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies. Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law. Contributors: T. Andia, M. Bourassa Forcier, M. Flynn, P. Gehl Sampath, S. Guennif, A. Guzman, H. Klug, G. Krikorian, N. Lalitha, J.-F. Morin, K.C. Shadlen, L. Shi, M. WatanabeTrade Review‘. . . this book will appeal strongly to a wide range of professionals, academics and students with interest in and involvement in public health issues worldwide, specifically the pharmaceutical industry. . . the book is timely, topical, and packed with carefully researched information which puts a number of major issues relating to pharmaceuticals in perspective. Of great value to researchers are the copious footnotes and extensive bibliographies which follow most of the articles. . . this book certainly provides you with an impressive mine of information if you find yourself having to argue your corner on any number of legal, economic and ethical issues in this complex field of study.’ -- Phillip Taylor MBE and Elizabeth Taylor, The Barrister Magazine‘Since the 1970s the pharmaceutical industry has undergone significant changes in its research and development paradigm, trade and production. Regulatory frameworks have also changed substantially, particularly in the area of intellectual property rights. This book provides much needed empirical evidence on the impact of these and other changes on the pharmaceutical sector and on access to medicines in developing countries. The studies, conducted with a common methodology, on nine developing countries (including major producers of pharmaceuticals such as China and India) and on Canada, make an outstanding contribution to the literature in the field. The data and analysis in the book are of immediate interest to policy makers and to scholars in various fields, including innovation economics, industrial policy, health systems and intellectual property.’ -- Carlos Correa, University of Buenos Aires, Argentina‘This impressive collection offers fascinating new perspectives on the impact of pharmaceutical patents on access to medicines in developing countries. The volume’s editors have put together an important book that sets out clearly the challenges to public health in a wide range of national contexts. The book will be a valuable text for all scholars and decision-makers interested in the global politics of intellectual property rights and public health.’ -- Duncan Matthews, Queen Mary, University of London, UKTable of ContentsContents: 1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha 2. Pharmaceutical Production and Access to Essential Medicines in South Africa Heinz Klug 3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy Gaëlle Krikorian 4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia Tatiana Andia 5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS Alenka Guzmán 6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program Matthew Flynn 7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies Kenneth C. Shadlen 8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience Jean-Frédéric Morin and Mélanie Bourassa Forcier 9. Access to Indian Generic Drugs: Emerging Issues N. Lalitha 10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China Mariko Watanabe and Luwen Shi 11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country Samira Guennif 12. The TRIPS Agreement and Health Innovation in Bangladesh Padmashree Gehl Sampath Index

Read more less

Book SynopsisThis book provides a detailed and comparative examination of medical patent law and the issues at the heart of the medical treatment exclusion for therapeutic treatments, surgical treatments and diagnostic methods. It first considers the historical basis for exclusion and the development of law and policy in Europe, the United States and other commonwealth countries. The book goes on to provide a detailed analysis of the issues related to new medical technologies, such as gene therapy, dosage regimes, and medical diagnostics, in light of the medical treatment exclusion. Medical Patent Law will strongly appeal to patent agents and attorneys, solicitors and barristers working in patent and intellectual property law and medical law worldwide, as well as medical practitioners and healthcare professionals; scientists, researchers and managers in the chemicals, medical; pharmaceuticals and biotechnology industries. Postgraduates on LLM medical law and intellectual property courses and academics specializing in medical law or patent law, will also find much to interest them.Trade Review‘Ventose makes a fresh, lively and incredibly thorough contribution to the literature in this work. He canvasses the European, English and American authorities in a systematic, methodical and - dare I say - surgical manner. The book is a ‘must read’ for practitioners, academics and students alike interested in patentable subject matter, public policy and medico-legal ethics. It will be a welcome addition to any legal collection.’ -- Emir Aly Crowne, University of Windsor, Barrister & Solicitor, Law Society of Upper Canada and Co-Founder and Co-Chair, Harold G. Fox Intellectual Property Moot‘Medical patents are a matter of life and death. Such patents have a critical impact upon patient care, medical research, and the administration of healthcare (and, indeed, are in part responsible for ballooning health care budgets). This comprehensive book by Eddy D. Ventose provides a systematic comparative analysis of medical patents. The work explores the historical taboo against patenting methods of human treatment; charts the spectrum of policy positions on medical patents, ranging from permissive to prohibitive; and examines contemporary battles over patenting methods of medical correlation in the Supreme Court of United States.’ -- Matthew Rimmer, The Australian National University College of Law and ACIPA, AustraliaTable of ContentsContents: Foreword Preface 1. Introduction 2. Arguments for Patent Protection 3. Arguments Against Patent Protection 4. Therapeutic Methods 5. Surgical Methods 6. Diagnostic Methods 7. Second and Further Medical Uses 8. Manner of New Manufacture 9. United Kingdom Patents Act 2004 10. United States of America 11. Conclusions Bibliography Index

Read more less

Book SynopsisThis book provides an overview of the US laws that affect clinical practice for healthcare professionals with no legal background.Divided into thirteen sections, each chapter starts with a summary of the chapter’s content and relevant legal concepts in bullet points before discussing the topics in detail. An application section is provided in many chapters to clarify essential issues by reflecting on clinically relevant case law or clinical vignette(s). Filling a crucial gap in the literature, this comprehensive guide gives healthcare professionals an understanding or a starting point to legal aspects of healthcare.Table of Contents1. Introduction to the US Legal System 2. Public Health Law 3. Law and Economics 4. Access to Care 5. Tort Law 6. Administrative Law 7. Federal Regulations 8. State Regulations 9. Antitrust Law 10. Mental Health Law 11. Labor and Employment Law 12. Reproductive Health Law 13. Insurance Law 14. Drug and Medical Device Law 15. Intellectual Property Law 16. Cannabis Law 17. Global Health Law 18. Law and Bioethics 19. Healthcare Reform

Read more less

Book SynopsisThis book brings together leading authorities from the fields of international human rights law, criminology, legal medicine, and political science with international human rights judges and UN experts to analyze the current situation of detainees in Europe, the Americas and Africa.This comprehensive volume offers a platform for reflecting on the complexity of the prison problem from a multidisciplinary perspective. The authors address detention-related issues with the aim of generating new ideas that contribute to both academic discussion and critical analysis. Academic dialogue across the globe provides insights into various national and international carceral systems and how they deal with human rights behind bars. At the same time, the critical comparison helps to identify basic needs and practices that can work in multiple settings. The contributors are respected experts and leading scholars in their fields, and each has pursued prison and human rights research over the last decades. However, this is the first time that they have come together in a multidisciplinary academic project. This book aims to stimulate diverse actors to imagine alternative ways of engaging with persons deprived of their liberty, in academia and in practice. Table of ContentsVulnerability in Prison Populations across Continents from a Multidisciplinary Perspective.- Part 1: Prison-Related Studies Of Judges, Un Experts And Commissioners.- Prison Overcrowding and the European Convention on Human Rights.- The UN Global Study on Children Deprived of Liberty: ‘Leaving No one behind, in Particular Children behind Bars.- The Implications of the Principle of Equality and Non-Discrimination on the Rights of Persons Deprived of Liberty in the Inter-American System.- Detention of Children and the African Human Rights System.- Part II: Prison-related Studies of Human Rights Scholars.- Solitary Confinement of Juveniles in Europe.- The Rights of Persons Deprived of Liberty in Latin America from the Perspective of an Ius Constitutionale Commune.- The Innovative Potential of Provisional Measures Resolutions for Detainee Rights in Latin America through Dialogue between the Inter-American Court and Other Courts.- Part III: Prison-related Studies of Scholars in Legal Medicine and Health.- Covid-19 – The Case for Re-thinking Health and Human Rights in Prison.- Human Rights and Prison Medicine – Protecting the Rights of Older Patients Deprived of Liberty.- Discontinuation of Medical Treatment – a Violation of Human Rights.- Part IV: Prison-related Studies of Criminologists and Political Scientists.- Monitoring Prisons: A Study of the Ongoing Dialogue between the European Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment and Belgium.- Solitary Confinement and the Meaning of ‘Meaningful Human Contact.- Torture Prevention in Latin America: Rights of Persons Deprived of Liberty and the Role of National Preventive Mechanisms.- Moving Forward in Protecting the Vulnerable Group of Prisoners.

Read more less

Book SynopsisMedizin- und Arztrechtssammlungen decken nur einen Teil rechtlicher Sachverhalte im betrieblichen Geschehen von Gesundheitseinrichtungen ab. Die Betriebsführung von Gesundheitsbetrieben umfasst jedoch über die rein medizinischen, pflegerischen Funktionen hinaus auch etwa die rechtlichen Aspekte des Einsatzes von Gesundheitspersonal, der Anwendung medizin-technischer Betriebsmittel, der Finanzierung oder auch des Rechnungswesens. Das vorliegende Buch bietet eine Übersicht der für die Betriebsführung eines Gesundheitsbetriebs wichtigen Bundesgesetze und -verordnungen und erläutert anhand von Beispielen die wesentlichen Aspekte. Es dient damit für alle Angehörigen des Gesundheitswesens als aktuelles Nachschlagewerk.Table of ContentsInhalt 1. Gesundheitsrechtliche Rahmenbedingungen (Allgemeines Gesundheitsrecht, Recht der gesetzlichen und privaten Krankenversicherung) 1.1 Arzneimittelausgaben-Begrenzungsgesetz (AABG) 1.2 Arzneimittelbudget-Ablösungsgesetz (ABAG) 1.3 GKV-Gesundheitsreformgesetz 2000 1.4 GKV-Solidaritätsstärkungsgesetz (GKV-SolG) 1.5 Gesundheits-Reformgesetz (GRG) 1.6 Gesundheitsstrukturgesetz 1.7 Heilmittelwerbegesetz (HWG) 1.8 Krankenversicherungs-Weiterentwicklungsgesetz (KVWG) 1.9 Reichsversicherungsordnung (RVO) 1.10 Sozialgesetzbuch (SGB) Fünftes Buch (V) - Gesetzliche Krankenversicherung - 1.11 Sozialgesetzbuch (SGB) - Elftes Buch (XI) - Soziale Pflegeversicherung 1.12 Verordnung über die Schiedsämter für die vertragsärztliche (vertragszahnärztliche) Versorgung (Schiedsamtsverordnung) 2. Wirtschaftsrechtliche Rahmenbedingungen (Allgemeines Wirtschaftsrecht) 2.1 Aktiengesetz (AktG) 2.2 Betriebsverfassungsgesetz (BetrVG) 2.3 Bürgerliches Gesetzbuch (BGB) 2.4 Gesetz betreffend die Gesellschaften mit beschränkter Haftung (GmbHG) 2.5 Gesetz gegen Wettbewerbsbeschränkungen (GWB) 2.6 Handelsgesetzbuch (HGB) Auszüge: 2.7 Partnerschaftsgesellschaftsgesetz (PartGG) 2.8 Scheckgesetz (ScheckG) 3. Patientenrecht (Pflegerecht) 3.1 Heimgesetz (HeimG) 3.2 Heimmindestbauverordnung (HeimMindBauV) 3.3 Heimmitwirkungsverordnung (HeimmwV) 3.4 Heimsicherungsverordnung (HeimsicherungsV) 3.5 Patientenbeteiligungsverordnung (PatBeteiligungsV) 4 Allgemeines Recht der Gesundheitsberufe (Medizinisches Berufsrecht 4.1 Approbationsordnung für Ärzte (ÄApprO 2002) 4.2 Zulassungsverordnung für Vertragsärzte (Ärzte-ZV) 4.3 Altenpflegegesetz (AltPflG) 4.4 Bundesärzteordnung (BÄO) 4.5 Ergotherapeutengesetz (ErgThG) 4.6 Hebammengesetz (HebG) 4.7 Heilpraktikergesetz (HeilprG) 4.8 Krankenpflegegesetz (KrPflG) 4.9 Gesetz über den Beruf des Logopäden (LogopG) 4.10 Gesetz über technische Assistenten in der Medizin (MTA-Gesetz - MTAG) 4.11 Orthoptistengesetz (OrthoptG) 4.12 Psychotherapeutengesetz (PsychThG) 4.13 Approbationsordnung für Zahnärzte (ZÄPrO) 4.14 Zahnheilkundegesetz (ZHG) 4.15 Zulassungsverordnung für Vertragszahnärzte (Zahnärzte-ZV) 5. Bereitstellung, Einsatz und Arbeitsschutz von Gesundheitspersonal (Betriebliches Arbeitsschutzrecht) 5.1 Gesetz über befristete Arbeitsverträge mit Ärzten in der Weiterbildung (ÄArbVtrG) 5.2 Arbeitsschutzgesetz (ArbSchG) 5.3 Arbeitsstättenverordnung (ArbStättV) 5.4 Arbeitszeitgesetz (ArbZG) 5.5 Arbeitnehmerüberlassungsgesetz (AÜG) 5.6 Behindertengleichstellungsgesetz (BGG) 5.7 Bildschirmarbeitsverordnung (BildscharbV) 5.8 Bundesurlaubsgesetz (BUrlG) 5.9 Heimpersonalverordnung (HeimPersV) 5.10 Jugendarbeitsschutzgesetz (JarbSchG) 5.11 Jugendarbeitsschutzuntersuchungsverordnung (JarbSchUV) 5.12 Kündigungsschutzgesetz (KSchG) 5.13 Mitbestimmungsgesetz (MitbestG) 5.14 Mutterschutzgesetz (MuSchG) 5.15 Verordnung zum Schutze der Mütter am Arbeitsplatz (MuSchuArbV) 5.16 Pflegearbeitsbedingungenverordnung (PflegeArbbV) 5.17 Teilzeit- und Befristungsgesetz (TzBfG) 6. Gesundheitsbetriebliche Aus- und Weiterbildung 6.1 Altenpflege-Ausbildungs- und Prüfungsverordnung - AltPflAPrV) 6.2 Verordnung über die fachliche Eignung für die Berufsausbildung der Medizinischen, Zahnmedizinischen und Tiermedizinischen Fachangestellten sowie der Pharmazeutisch-kaufmännischen Angestellten (AusbEignMedPharmV) 6.3 Berufsbildungsgesetz (BBiG) 6.4 Ergotherapeuten-Ausbildungs- und Prüfungsverordnung - ErgThAPrV) 6.5 Verordnung über die Prüfung zum anerkannten Fortbildungsabschluss Geprüfter Fachwirt im Gesundheits- und Sozialwesen und Geprüfte Fachwirtin im Gesundheits- und Sozialwesen (GesWFachwPrV) 6.6 Ausbildungs- und Prüfungsverordnung für Hebammen und Entbindungspfleger (HebAPrV) 6.7 Verordnung über die Berufsausbildung für Kaufleute in den Dienstleistungsbereichen Gesundheitswesen sowie Veranstaltungswirtschaft (KflDiAusbV) 6.8 Ausbildungs- und Prüfungsverordnung für Kinder- und Jugendlichenpsychotherapeuten (KJPsychTh-APrV) 6.9 Ausbildungs- und Prüfungsverordnung für die Berufe in der Krankenpflege (KrPflAPrV) 6.10 Ausbildungs- und Prüfungsordnung für Logopäden (LogAPrO) 6.11 Verordnung über die Berufsausbildung zum Medizinischen Fachangestellten/zur Medizinischen Fachangestellten (MedFAngAusbV) 6.12 Verordnung über die Ausbildungsförderung für Medizinalfachberufe (MedizinalfachberufeV) 6.13 Ausbildungs- und Prüfungsverordnung für technische Assistenten in der Medizin (MTA-APrV) 6.14 Ausbildungs- und Prüfungsverordnung für Orthoptistinnen und Orthoptisten (OrthoptAPrV) 6.15 Ausbildungs- und Prüfungsverordnung für Psychologische Psychotherapeuten (PsychTh-APrV) 6.16 Ausbildungs- und Prüfungsverordnung für pharmazeutisch-technische Assistentinnen und pharmazeutisch-technische Assistenten (PTA-APrV) 6.17 Verordnung über die Ausbildungsförderung für soziale Pflegeberufe (SozPflegerV) 6.18 Verordnung über die Berufsausbildung zum Zahnmedizinischen Fachangestellten/zur Zahnmedizinischen Fachangestellten (ZahnmedAusbV) 7. Medizinische Leistungserstellung und Betriebsmitteleinsatz (Arzneimittel- und Medizinprodukterecht) 7.1 Arzneimittelgesetz (AMG) 7.2 Verordnung über apothekenpflichtige und freiverkäufliche Arzneimittel (AMVerkRV) 7.3 Arzneimittelverschreibungsverordnung (AMVV) 7.4 Biostoffverordnung (BioStoffV) 7.5 Betäubungsmittelgesetz (BtMG) 7.6 Betäubungsmittel-Verschreibungsverordnung (BtMVV) 7.7 Chemikaliengesetz (ChemG) 7.8 Gefahrstoffverordnung (GefStoffV) 7.9 Gentechnik-Sicherheitsverordnung (GenTSV) 7.10 Infektionsschutzgesetz (IfSG) 7.11 Kaliumiodidverordnung (KIV) 7.12 Kreislaufwirtschaftsgesetz (KrWG) 7.13 Medizinprodukte-Betreiberverordnung (MPBetreibV) 7.14 Medizinproduktegesetz (MPG) 7.15 Verordnung über klinische Prüfungen von Medizinprodukten (MPKPV) 7.16 Verordnung über die Verschreibungspflicht von Medizinprodukten (MPVerschrV) 7.17 Medizinprodukte-Sicherheitsplanverordnung (MPSV) 7.18 Gesetz zum Schutz vor nichtionisierender Strahlung bei der Anwendung am Menschen (NiSG) 7.19 Röntgenverordnung (RöV) 7.20 Transfusionsgesetz (TFG) 7.21 Transplantationsgesetz (TPG) 7.22 TPG-Gewebeverordnung (TPG-GewV) 7.23 Strahlenschutzverordnung (StrlSchV) 8. Gesundheitsbetriebliche Finanzierung und Einnahmenerzielung (Gebührenrecht, Krankenhausrecht, Privatversicherungsrecht) 8.1 Abgrenzungsverordnung (AbgrV) 8.2 Gesetz zur Einführung des Wohnortprinzips bei Honorarvereinbarungen für Ärzte und Zahnärzte (ArztWohnortG) 8.3 Bundespflegesatzverordnung (BPflV) 8.4 Gebührenordnung für Ärzte (GOÄ) 8.5 Gebührenordnung für Psychologische Psychotherapeuten und Kinder- und Jugendlichenpsychotherapeuten (GOP) 8.6 Gebührenordnung für Zahnärzte (GOZ) 8.7 Krankenhausentgeltgesetz (KHEntgG) 8.8. Gesetz zur wirtschaftlichen Sicherung der Krankenhäuser und zur Regelung der Krankenhauspflegesätze (Krankenhausfinanzierungsgesetz - KHG) 8.9 Nutzungszuschlags-Gesetz (NutzZG) 9. Rechnungswesen des Gesundheitsbetriebs 9.1 Krankenhaus-Buchführungsverordnung (KHBV) 9.2 Pflege-Buchführungsverordnung (PBV) 9.3 Publizitätsgesetz (PublG) 10. Gesundheitsbetriebliches Informationswesen (Datenverarbeitung und Statistik) 10.1 Bundesdatenschutzgesetz (BDSG) 10.2 Krankenhausstatistik-Verordnung (KHStatV) 10.3 Pflegestatistik-Verordnung - PflegeStatV)

Read more less

Book SynopsisThis book provides guidance to all professionals working with children who present with injuries, neglect, illness falsification and other forms of child abuse. Clinical findings and the current literature are analyzed. The author’s clinical experience is shared to assist the reader in diagnosing the cause of injury and other presentations. This text is the result of many years of experience in the UK working with children in an East London hospital (which receives over 1000 children a week through the children’s Emergency Department) and the analysis of over 400 cases for the Family and Crown Courts. Mainstream opinions, the medical literature, and examples from extensive experience on the wards and in Court are discussed. Pediatric Forensic Evidence is aimed at doctors, lawyers, the Courts, social workers, health visitors, teachers, the police and others, guiding them through the analysis of injury and when to raise concerns.Trade Review“This is a comprehensive, clinically relevant resource for providers involved in the evaluation and care of children who are seen for suspected child abuse or neglect. …The audience includes students, nurses, nurse practitioners, physician assistants, residents, fellows, and practitioners. … This is an excellent resource for providers at every level who are evaluating children for potential child abuse and neglect. The approach is excellent, the objectives are met, and I can recommend this book without hesitation.” (Joseph Hageman, Doody's Book Reviews, May, 2018)Table of ContentsGeneral Aspects of Child Protection.- Bruising in Infants & Children.- Fractures.- Burns.- Abusive Head Trauma (AHT).- Abdominal and Thoracic Trauma.- Neglect and Emotional Abuse.- Fabricated or Induced Illness by Carers (FII).- Child sexual abuse.

Read more less

Book SynopsisThis volume links three different theoretical approaches that have a common focus on the relationship between biopolitics and bioethics. This collection of papers can be categorized into different domains that are representative of the contemporary usage of biopolitics as a concept. On the one hand, several chapters develop a clear and up-to-date understanding of the primary sources of the concept and related theories of Agamben, Negri or Foucault and approach the question of relevance within the field of bioethics. Another group of papers apply the philosophical concepts and theories of biopolitics (biopower, Homo Sacer, biocitizenship) on very specific currently debated bioethical issues. Some scholars rely on the more mundane understanding of (bio)politics and investigate how its relationship with bioethics could be philosophically conceptualized. Additionally, this work also contains papers that follow a more legally oriented analysis on the effects of contemporary biopolitics on human rights and European law. The authors are philosophers, legal scholars or bioethicists. The major strength of this volume is to provide the reader with major insights and orientation in these different contemporary usages of the concept and theories of biopolitics, within the context of its various ethically relevant applications.Table of ContentsIntroduction to the volume: Perspectives on biopolitics and bioethics; Péter Kakuk.- Biopolitics and Biopower. The Foucauldian Heritage in the Light of the Contemporary Usage; Takács, Ádám.- How to get plump, or why do we choose what we choose?; Devisch, Ignaas.- preface:Theories of biopolitics and bioethical issues; Péter Kakuk.- Biological or Democratic Citizenship?; Árnason, Vilhjálmur.- Biopolitics and the Longevity of Lefthanders ; Arnason, Gardar.- Chronic Disorders of Consciousness and Homo Sacer; Edgar, Andrew.- Government, Big Pharma and the Exercise of Biopower: The ethical acceptability of lobbying and promotion; Badcott, David.- preface: Biopolitics and legal discourse; Péter Kakuk.- The ME MOLECULE; Sándor, Judit.- Of Emerging Life in Law: the European Story; Selkälä, Toni.- Beyond bioethics and biopolitics? Doing privacy ethics in whole Genome sequencing research; Schickhardt, Christoph & Winker, Eva C.- preface: Questions of relatedness: bioethics and biopolitics; Péter Kakuk.- Can bioethics escape from biopolitics?; ten Have, Henk.- Bioethics as politics Takala, Tuija.- On the relationship between bioethics and biopolitics; Gunson, Darryl.

Read more less

Book SynopsisDas vorliegende Handbuch liefert einen konzisen Überblick und eine verlässliche Orientierungshilfe bei ethischen und rechtlichen Entscheidungsprozessen in der Forschung am Menschen. Es dient dabei einerseits als eine Dokumentation des Status quo, andererseits aber auch als Diskussionsgrundlage für zukünftige Entwicklungen. An dem Handbuch haben Praktiker aus Forschung und medizinischer Behandlung, Ethiker und Philosophen, Medizinhistoriker, Rechtswissenschaftler, Pharmakologen, Strahlentherapeuten, Pädiater, Chirurgen und Psychiater mitgearbeitet, die für eine hohe Detailkenntnis und Praxisrelevanz der gesammelten Beiträge bürgen. Das Buch gibt Ethikkommissionsmitgliedern, Forschern und Antragstellern bei Ethikkommissionen einen Einblick in Krite­rien und Entscheidungsmechanismen der Forschungsethik und macht Entscheidun­gen und Beurteilungen von Ethikkommissionen besser verständlich. Darüber hinaus liefert es einen Beitrag zu einer Harmonisierung der bestehenden Praxis.Trade Review“... eine gelungene Mischung zwischen eher theoretisch und eher praktisch ausgerichteten Beiträgen aus. ... Insgesamt lässt sich feststellen, dass das Handbuch einen hervorragenden Überblick über nahezu alle mit Humanexperimenten verbundenen ethischen, rechtlichen und praktischen Themenfelder vermittelt … Zweifelsohne handelt es sich bei dem Handbuch um ein Vademekum im besten Sinne des Wortes – ein Wegbegleiter, der in die Handbibliothek eines jeden gehört, der sich theoretisch oder praktisch mit der Forschung am Menschen befasst.” (Ulrich M. Gassner, in: MedR Medizinrecht, Jg. 33, Heft 5, Mai 2015)“... Der lexikalische Charakter macht das Handbuch zu einer seriösen Quelle der rechtlichen und ethischen Normen in der medizinischen Forschung. Das Buch verdeutlich, wie intensiv man sich in Deutschland mit rechtlichen Bestimmungen, Verfahrensregeln und moralischen Standards um eine Bewertung und Regelung in diesem Bereich bemüht.” (in: EB Erwachsenenbildung, Heft 1, Januar 2015)Table of ContentsTeil I: Art der Studie.- Teil II: Zentrale ethische und rechtliche Themen.- Teil III: Patientengruppen.- Teil IV: Forschungsbereiche.- Teil V: Dokumente und Institutionen.- Teil VI: Fachbegriffe zur Studiendurchführung.

Read more less

Book SynopsisJuristen, Ärzte, Pharmakologen und Apotheker finden in diesem Werk vier wesentliche Aspekte des Medizinrechts: das Arztrecht, das Arzneimittelrecht, das Recht der Medizinprodukte und das Transfusionsrecht. Die rechtliche Darstellung medizinischer, pharmazeutischer und medizintechnischer sowie transplantations- und transfusionsrechtlicher Probleme verdeutlichen Entscheidungen und praktische Fälle. Ein Blick auf ausländische Entscheidungen, Regeln und Tendenzen rundet das Bild ab. Europarechtliche Vorgaben werden eingehend beleuchtet. Die 7. Auflage setzt neue Akzente im Bereich des Transplantationsrechts, der Patientenverfügung und der Sterbebegleitung und zeigt neuere Entwicklungen in Europa im Recht der medizinischen Forschung, auch an Tieren. Wegen der genauen Gliederung und des ausführlichen Registers ist das Buch auch als Nachschlagewerk geeignet.Trade Review“... Dieses Buch ist nicht nur ein Handbuch, das eine vertiefte Übersicht darüber, was das Medizinrecht in seiner Gesamtheit heute ist, bietet und die einzelnen behandelten Themen gründlich aufarbeitet. Dieses Buch ist mindestens ebenso gut als Lehrbuch und sogar als Repetierhilfe nutzbar ...“ (Adrian Schmidt-Recla, in: MedizinRecht, Jg. 33, 2015, S. 146)Table of ContentsArztrecht.- Arzneimittelrecht.- Medizinprodukterecht.- Transfusionsrecht.- Anhang.

Read more less

Book SynopsisBei der Patientenverfügung handelt es sich um ein Rechtsinstrument des Einzelnen zur Sicherstellung seines Selbstbestimmungsrechts im Zustand der Einwilligungsunfähigkeit am Lebensende. Aufgabe des Arztes ist es, die Patientenverfügung in der konkreten Behandlungssituation umzusetzen. Unterlaufen diesem Fehlinterpretationen der in einer Patientenverfügung getroffenen Festlegungen und handelt er danach, drohen ihm erhebliche straf-, zivil- und berufsrechtliche Folgen. Im Rahmen der Untersuchung konnte ermittelt werden, dass die Ergänzung der gesetzlichen Normierung der Patientenverfügung in den §§ 1901a ff. BGB durch weitere rechtliche Vorgaben wie eine Aufklärungs- und Beratungspflicht bei negativen Patientenverfügungen, eine Aktualisierungspflicht sowie eine Registrierungs- und Hinterlegungspflicht bei negativen und positiven Patientenverfügungen den Eintritt dieser Folgen ggf. verringern könnte. Es ist davon auszugehen, dass dadurch das Risiko einer fehlerhaften Entscheidung für den Arzt im Umgang mit einer Patientenverfügung zumindest in einem entscheidenden Maß reduziert werden könnte. Vice versa könnte durch die Senkung des Risikos einer Fehlinterpretation der in einer Patientenverfügung getroffenen Festlegungen wiederrum die Gefahr, dem selbstbestimmten Patientenwillen nicht oder fehlerhaft umzusetzen, mithin einer Fremdbestimmung entgegengewirkt werden und somit die Patientenverfügung dem Einzelnen als effektive(re)s Rechtsmittel dienen. Table of ContentsDie Selbstbestimmung in Medizin und Recht – Bedeutung für Arzt und Patient.- Die Patientenverfügung als Ausdruck individualisierter Selbstbestimmung –Entwicklung der öffentlichen Debatte um das Erfordernis einer gesetzlichen Regulierungund ihre Implementierung durch das 3. BtÄndG.- Die gesetzliche Implementierung des Rechtsinstituts der Patientenverfügungde lege lata – §§ 1901a ff. BGB.- Die Verantwortlichkeit des Arztes im Umgang mit dem Rechtsinstitut derPatientenverfügung – Eine straf-, zivil- und standesrechtliche Betrachtung.- Beurteilung und (Auf-)Lösungsansätze zum SpannungsverhältnisSelbstbestimmung des Patienten versus Verantwortlichkeit des Arztes.

Read more less

Book SynopsisGutachten erstellen – dies erfordert Wissen und den Blick über den Tellerrand!Als Gutachter stellen Sie ihr Fachwissen und ihre Kompetenz Gerichten, Behörden, Versicherungen und anderen Auftraggebern zur Verfügung. Hier finden Sie alles über die Grundlagen und Besonderheiten bei der Gutachtenerstellung und profitieren von der langjährigen Erfahrung der Autoren:Basiswissen nachlesen Rechtsgrundlagen und Aufgaben der Begutachtung Organbezogene Darstellung der Erkrankungen Kausalitäten erkennen und Systematik anwendenIn jedem Kapitel enthalten: Diagnostik Krankheitsdefinition Fragen zum Zusammenhang Bewertung nach dem Sozialrecht Fragestellungen aus der Privatversicherung Hinweise zur Prognose Risikobeurteilung und Verbesserung durch Rehabilitation Praxisplus Leitlinien für die Begutachtung Abrechnungsbeispiele und Tabellen zu Vergütungen Internetadressen NEU:Erweitert um ICF sowie Rechtsgrundlagen für Schweiz und ÖsterreichSowohl für jeden ärztlichen Gutachter als auch für den Auftraggeber von Gutachten als Nachschlagewerk bestens geeignet!Trade Review“... Das kompakte Werk kann jedem medizinischen Gutachter ohne Einschränkung empfohlen werden, es enthält wichtige Informationen für Nicht-Mediziner (Juristen, Sachbearbeiter etc.) und bietet auch Rechtsmediziner/innen im Einzelfall gutachterlich wertvolle Informationen.” (R. Dettmeyer, in: Der Urologe, Heft 2, 1. Februar 2017)Table of ContentsGrundlagen.- Rechtliche Grundlagen.- Grundbegriffe der Begutachtung.- Die Vergütung des medizinischen Sachverständigen.- Organe und die Begutachtung ihrer Krankheiten.- Bewegungsapparat.- Herz.- Periphere Gefäße.- Respirationstrakt.- Leber - Gallenwege - Pankreas.- Gastrointestinaltrakt.- Haut und Hautanhangsgebilde.- Nervensystem.- Sinnesorgane.- Endokrine Organe.- Nierenkrankheiten.- Weibliche Geschlechtsorgane.- System- bzw. nicht organbezogene Krankheiten und ihre Begutachtung.- Diabetes mellitus.- Hypertonie.- Psychiatrische Begutachtung.- Interdisziplinäre Onkologie - Tumorerkrankungen und deren Folgen.- Stichwortverzeichnis.

Read more less

Book SynopsisDer Band „Facetten von Gesundheitskompetenz in einer Gesellschaft der Vielfalt“ zeichnet ein vielseitiges Bild über die Bedeutung von Gesundheit und Gesundheitskompetenz in einer Gesellschaft, die von zunehmender Diversität, digitaler Transformation und immer leistungsfähigerer Medizin geprägt ist. Gesundheitskompetenz, also Gesundheitsinformationen finden, verstehen, beurteilen und anwenden zu können, ist ein Zusammenspiel von individuellen Fähigkeiten und institutionellen Anforderungen. Wie können Gesundheitsinformationen aufbereitet werden, um für alle Menschen angemessen zugänglich und verständlich zu sein? Woran erkennen wir gute Gesundheitsinformationen? Wie können VertreterInnen unterschiedlicher Gesundheitsprofessionen selbstbestimmte Gesundheitsentscheidungen fördern? Diese und anderen Fragen werden u.a. aus gesundheitspsychologischer, soziologischer und ethischer Perspektive beleuchtet. Die AutorInnen geben Einblicke in die aktuelle Forschung, stellen ausgewählte Arbeiten vor und laden zur Reflexion über unseren Umgang mit Gesundheit und Gesundheitsinformationen ein.

Read more less

Book SynopsisDer Privatpatient.- Der Kassenpatient.- Der Arzt und die KV.- Der Arzt und die besonderen Versorgungsformen.- Ärztliches Standesrecht.- Der Arzt und das Disziplinarrecht/Zulassungsentziehung.- Der Arzt und das Strafrecht.- Der Arzt und die berufliche Kooperation.- Arzthaftpflichtrecht.- Der Arzt und das Arbeitsrecht.- Der Arzt und das Mietrecht.- Praxiskauf und Praxisabgabe.- Der Arzt und das Familienrecht.

Read more less

Book Synopsis

Read more less

Book SynopsisWith the increasing number of complaints and court cases relating to healthcare disputes, healthcare practitioners (HCPs) are now facing more challenges and dilemmas in their daily practices. This book is unique in that most chapters are written jointly by two authors: one with legal training and one with a healthcare background. The balanced view offered thus allows readers to gain a thorough understanding of the concepts presented. Although most of the examples and scenarios are specific to medical doctors, the basic principles and ethical considerations as well as the enforcement of laws and regulations are, with some modifications, equally applicable to other HCPs, such as dentists, nurses, midwives, etc. Readers interested in healthcare law and ethics from numerous fields and stages of training, including legal and healthcare practitioners, trainees, postgraduate researchers and undergraduate students, will find this book both informative and practical as an aid to their work and studies.

Read more less

Book SynopsisA Multidisciplinary Perspective on Cross-Border Health Data Transfers: Privacy, Risks and Solutions.- The EU-US Data Privacy Framework: Is the Dragon Eating its Own Tail?.- Unlocking the Potential of Binding Corporate Rules (BCRs) in Health Data Transfers.- International Health Data Transfers in the United Kingdom: The Legal Framework.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less